Document:

Exhibit 4.1

 

THE ISSUANCE AND SALE OF THE SECURITIES
REPRESENTED BY THIS DEBENTURE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES
LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION
STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE
SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT
TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA
FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.

 

MEDYTOX SOLUTIONS, INC.

 

SENIOR SECURED, CONVERTIBLE, REDEEMABLE
DEBENTURE

 

	Dated as of:  May 31, 2015	 	Principal Amount: $3,000,000.00
	Effective Date: September 11, 2015	 	 
	Maturity Date: September 11, 2017	 	 

 

This SENIOR
SECURED, CONVERTIBLE REDEEMABLE DEBENTURE (the “Debenture”) is issued, dated as of May 31, 2015 and effective
as of September 11, 2015 (the “Effective Date”), by MEDYTOX SOLUTIONS, INC., a corporation incorporated under
the laws of the State of Nevada (the “Company”), to TCA GLOBAL CREDIT MASTER FUND, LP, a limited partnership
organized and existing under the laws of the Cayman Islands (together with its permitted successors and assigns, the “Holder”)
pursuant to exemptions from registration under the Securities Act of 1933, as amended. This Debenture is issued in connection with
that certain Securities Purchase Agreement, dated as of the date hereof, by and between the Company and the Holder (the “Purchase
Agreement”). All capitalized terms used in this Debenture and not otherwise defined herein shall have the meanings assigned
to them in the Purchase Agreement.

 

ARTICLE I

 

Section
1.01Principal and Interest. For value received, the Company hereby promises to pay to the order of the Holder, by no
later than September 11, 2017 (the “Maturity Date”), in immediately available and lawful money of the United
States of America, Three Million and No/100 United States Dollars ($3,000,000.00), together with interest on the outstanding principal
amount under this Debenture, at the rate of sixteen percent (16%) per annum simple interest (the “Interest Rate”)
from the Effective Date, until paid, as more specifically provided below.

 

 

    	 	1	 

     

    

 

 

Section
1.02 Optional Redemption Prior to Maturity. The Company, at its option, shall have the right to redeem this Debenture in
full and for cash, at any time prior to the Maturity Date, with three (3) business days advance written notice (the “Redemption
Notice”) to the Holder. The amount required to redeem this Debenture in full pursuant to this Section 1.02 shall be equal
to: (i) the aggregate principal amount then outstanding under this Debenture; plus all accrued and unpaid interest due under this
Debenture as of the redemption date; plus (ii) all other costs, fees and charges due and payable hereunder or under any other “Transaction
Documents” (as hereinafter defined), including, but not limited to, any prepayment penalties provided for in the Purchase
Agreement (collectively, the “Redemption Amount”). The Company shall deliver the Redemption Amount to the Holder
on the third (3rd) business day after the date of the Redemption Notice.

 

Section
1.03 Mandatory Redemption at Maturity. On the Maturity Date, the Company shall redeem this Debenture for the Redemption
Amount, which Redemption Amount shall be due and payable to the Holder by no later than 2:00 P.M., EST, on the Maturity Date.

 

Section 1.04Payments.

 

(1)    
Monthly Payments. The Company shall make monthly payments of principal and interest
to the Holder, while this Debenture is outstanding, until the Maturity Date, based on the payment and amortization schedule attached
hereto as Schedule A. In the event such day is not a Business Day, then said payment shall be due on the first Business
Day thereafter occurring. 

 

(2)     
Interest Calculations; Payment Application. Interest shall be calculated on
the basis of a 360-day year, and shall accrue daily on the outstanding principal amount outstanding from time to time for the actual
number of days elapsed, commencing on the Effective Date until payment in full of the outstanding principal, together with all
accrued and unpaid interest and other amounts which may become due hereunder or under any Transaction Documents, has been made.
All payments received and actually collected by Holder hereunder shall be applied first to any costs and expenses due or incurred
hereunder or under any other Transaction Documents, second to accrued and unpaid interest hereunder, and last to reduce the outstanding
principal balance of this Debenture.

 

(3)     
Late Fee. If all or any portion of the payments of principal, interest or other
charges due hereunder are not received by the Holder within five (5) days of the date such payment is due, then the Company shall
pay to the Holder a late charge (in addition to any other remedies that Holder may have) equal to five percent (5%) of each such
unpaid payment or sum. Any payments returned to Holder for any reason must be covered by wire transfer of immediately available
funds to an account designated by Holder, plus a $100.00 administrative fee charge. Holder shall have no responsibility or liability
for payments purportedly made hereunder but not actually received by Holder; and the Company shall not be discharged from the obligation
to make such payments due to loss of same in the mails or due to any other excuse or justification ultimately involving facts where
such payments were not actually received by Holder.

 

 

    	 	2	 

     

    

 

Section
1.05. Manner of Payments. All sums payable to the order of Holder hereunder shall be payable by ACH transfer of lawful dollars
of the United States of America to the ACH instructions set forth below, or at such place as Holder, from time to time, may designate
in writing. ACH Instructions for all sums due and payable hereunder are as follows:

 

	Bank Name:  	Bank of America
	Bank Address:  	100 W. 33rd Street, New York, NY 10001
	Beneficiary Account Name:  	TCA Fund Mgmt Group
	Beneficiary Account Number: 	898052439174
	ACH Transfer/Routing Number:  	063100277
	SWIFT:  	BOFAUS3N

 

ARTICLE II

 

Section
2.01Secured Nature of Debenture. This Debenture is being issued in connection with the Purchase Agreement. The indebtedness
evidenced by this Debenture is also secured by all of the assets and property of the Company and various other instruments and
documents referred to in the Purchase Agreement as the “Transaction Documents”. All of the agreements, conditions,
covenants, provisions, representations, warranties and stipulations contained in any of the Transaction Documents which are to
be kept and performed by the Company are hereby made a part of this Debenture to the same extent and with the same force and effect
as if they were fully set forth herein, and the Company covenants and agrees to keep and perform them, or cause them to be kept
or performed, strictly in accordance with their terms.

 

ARTICLE III

 

Section
3.01Events of Default. The occurrence and continuance of any of the following events shall constitute an “Event
of Default” hereunder:

 

		(i)	the Company and/or Guarantors shall fail to pay any interest, principal
or other charges due under this Debenture or any other Transaction Documents on the date five (5) days after any such payment shall
be due and payable (whether by acceleration, declaration, extension or otherwise);

		(ii)	the Company and/or Guarantors makes
an assignment for the benefit of creditors; 

		(iii)	any order or decree is rendered by a court
which appoints or requires the appointment of a receiver, liquidator or trustee for the Company and/or Guarantors,
and the order or decree is not vacated within thirty (30) days from the date of entry thereof; 

		(iv)	any order or decree is rendered by a court
adjudicating the Company and/or Guarantors insolvent, and the order or decree is not vacated
within thirty (30) days from the date of entry thereof; 

		(v)	the Company and/or Guarantors files
a petition in bankruptcy under the provisions of any bankruptcy law or any insolvency act; 

		(vi)	the Company and/or Guarantors admits,
in writing, its insolvency or its inability to pay its debts as they become due; 

		(vii)	a proceeding or petition in bankruptcy is
filed against the Company and/or Guarantors and such proceeding or petition is not dismissed
within thirty (30) days from the date it is filed; 

 

 

 

    	 	3	 

     

    

 

 

		(viii)	the Company and/or Guarantors files
a petition or answer seeking reorganization or arrangement under the bankruptcy laws or any law or statute of the United States
or any other foreign country or state; 

		(ix)	any written warranty, representation, certificate or statement of the Company
and/or Guarantors in this Debenture, the Purchase Agreement, any other Transaction Document, any financial statement, application,
schedule report or any other document given by the Company and/or Guarantors to the Holder, or any other agreement with Holder
shall be false or misleading in any material respect when made or deemed made, or if the Company and/or Guarantors omitted to state
any material fact or fact necessary to make such information not misleading, and such misstatement or omission remains uncured
for a period of five (5) days following written notice from the Holder to the Company and/or Guarantors;

		(x)	the Company and/or Guarantors
shall fail to perform, comply with or abide by any of the stipulations, agreements, conditions and/or covenants contained in this
Debenture, the Purchase Agreement or any of the other Transaction Documents on the part of the Company and/or Guarantors
to be performed complied with or abided by, and such failure continues or remains uncured for fifteen (15) days following written
notice from the Holder to the Company and/or Guarantors;

		(xi)	the occurrence of any default under any other borrowing, Obligation or Contract
of the Company and/or Guarantors, except for equipment leases, if the result of such default would: (i) permit any Person which
is a party to any such borrowing, Obligation or Contract, to accelerate the maturity thereof, or to cancel or terminate any such
borrowing, Obligation or Contract, the result of which would have a Material Adverse Effect on the Company; (ii) cause or be reasonably
expected to cause a Material Adverse Effect; or (iii) materially and adversely affect, as determined by the Holder in good faith,
but in its sole discretion, any of the Collateral, the value thereof, the Holder’s rights and remedies to realize upon such
Collateral as set forth herein, or the Holder’s ability to comply with the Transaction Documents and such default remains
uncured for a period of five (5) days following written notice from the Holder to the Company and/or Guarantors;

		(xii)	the entry of any final and non-appealable Judgment or other determination
or adjudication against the Company and/or Guarantors and a determination by the Holder, in good faith but in its sole discretion,
that any such Judgment or other determination or adjudication would cause or would be reasonably expected to cause a Material Adverse
Effect, or would otherwise adversely affect the prospect for the Holder to fully and punctually realize the full benefits conferred
on the Holder by this Debenture, the Purchase Agreement, the Security Agreements and the other Transaction Documents, or the prospect
of repayment of all the Obligations;

		(xiii)	the injunction or restraint of the Company and/or Guarantors in any manner
from conducting its business in whole or in part and a determination by Holder, in good faith but in its sole discretion, that
the same would cause or would be reasonably expected to cause a Material Adverse Effect, or would otherwise adversely affect the
prospect for the Holder to fully and punctually realize the full benefits conferred on the Holder by this Debenture, the Purchase
Agreement, the Security Agreements and the other Transaction Documents, or the prospect of repayment of all the Obligations and
such injunction or restrain shall continue for a period of five (5) days following written notice from the Holder to the Company
and/or Guarantors;

 

 

    	 	4	 

     

    

 

 

		(xiv)	any Assets of the Company and/or Guarantors shall be attached, levied upon,
seized or repossessed, or come into the possession of a trustee, receiver or other custodian and a determination by the Holder,
in good faith but in its sole discretion, that the same would cause or would be reasonably expected to cause a Material Adverse
Effect, or would otherwise adversely affect the prospect for the Holder to fully and punctually realize the full benefits conferred
on the Holder by this Debenture, the Purchase Agreement, the Security Agreements and the other Transaction Documents, or the prospect
of repayment of all the Obligations, and the same remains uncured for a period of five (5) days following written notice from the
Holder to the Company and/or Guarantors;

		(xv)	the determination in good faith by Holder that an event has occurred, either
in the financial condition or operations of the Company and/or Guarantors, or the Collateral, or otherwise, which event would cause
or would be reasonably expected to cause a Material Adverse Effect, or would otherwise adversely affect the prospect for Holder
to fully and punctually realize the full benefits conferred on Holder by this Debenture, the Purchase Agreement, the Security Agreements
and the other Transaction Documents; and

		(xvi)	the determination in good faith by Holder that the security for the Obligations
is or has become inadequate and shall continue to be inadequate for a period of five (5) days following written notice from the
Holder to the Company and/or Guarantors; and

 

Section
3.02Remedies. Upon the occurrence of an Event of Default that is not timely cured within an applicable cure period hereunder,
the interest on this Debenture shall immediately accrue at an interest rate equal to the lesser of (i) twenty-two percent (22%)
per annum or (ii) the maximum interest rate allowable by law, and, in addition to all other rights or remedies the Holder may have,
at law or in equity, the Holder may, in its sole discretion, accelerate full repayment of all principal amounts outstanding hereunder,
together with accrued interest thereon, together with all reasonable attorneys’ fees, paralegals’ fees and costs and
expenses incurred by the Holder in collecting or enforcing payment hereof (whether such fees, costs or expenses are incurred in
negotiations, all trial and appellate levels, administrative proceedings, bankruptcy proceedings or otherwise), and together with
all other sums due by the Company hereunder and under the Transaction Documents, all without any relief whatsoever from any valuation
or appraisement laws, and payment thereof may be enforced and recovered in whole or in part at any time by one or more of the remedies
provided to the Holder at law, in equity, or under this Debenture or any of the other Transaction Documents. In connection with
the Holder’s rights hereunder upon an Event of Default, the Holder need not provide, and the Company hereby waives, any presentment,
demand, protest or other notice of any kind, and the Holder may immediately enforce any and all of its rights and remedies hereunder
and all other remedies available to it in equity or under applicable law.

 

 

    	 	5	 

     

    

 

ARTICLE IV

 

Section
4.01 Usury Savings Clause. Notwithstanding any provision in this Debenture or the other Transaction Documents to the contrary,
the total liability for payments of interest and payments in the nature of interest, including, without limitation, all charges,
fees, exactions, or other sums which may at any time be deemed to be interest, shall not exceed the limit imposed by the usury
laws of the jurisdiction governing this Debenture or any other applicable law. In the event the total liability of payments of
interest and payments in the nature of interest, including, without limitation, all charges, fees, exactions or other sums which
may at any time be deemed to be interest, shall, for any reason whatsoever, result in an effective rate of interest, which for
any month or other interest payment period exceeds the limit imposed by the usury laws of the jurisdiction governing this Debenture,
all sums in excess of those lawfully collectible as interest for the period in question shall, without further agreement or notice
by, between, or to any party hereto, be applied to the reduction of the outstanding principal balance due hereunder immediately
upon receipt of such sums by the Holder hereof, with the same force and effect as though the Company had specifically designated
such excess sums to be so applied to the reduction of the principal balance then outstanding, and the Holder hereof had agreed
to accept such sums as a penalty-free payment of principal; provided, however, that the Holder may, at any time and from time to
time, elect, by notice in writing to the Company, to waive, reduce, or limit the collection of any sums in excess of those lawfully
collectible as interest, rather than accept such sums as a prepayment of the principal balance then outstanding. It is the intention
of the parties that the Company does not intend or expect to pay, nor does the Holder intend or expect to charge or collect any
interest under this Debenture greater than the highest non-usurious rate of interest which may be charged under applicable law.

 

ARTICLE V

 

Section 5.01No
Exemption. The Company hereby waives and releases all benefit that might accrue to the Company by virtue of any present or
future laws exempting any property that may serve as security for this Debenture, or any other property, real or personal, or any
part of the proceeds arising from any sale of any such property, from attachment, levy, or sale under execution, exemption from
civil process, or extension of time for payment; and the Company agrees that any property that may be levied upon pursuant to a
judgment obtained by virtue hereof, on any writ of execution issued thereon, may be sold upon any such writ in whole or in part
in any order or manner desired by Holder.

 

Section
5.02 Exercise of Remedies. The remedies of the Holder as provided herein and in any of the other Transaction Documents shall
be cumulative and concurrent and may be pursued singly, successively or together, at the sole discretion of the Holder, and may
be exercised as often as occasion therefor shall occur; and the failure to exercise any such right or remedy shall in no event
be construed as a waiver or release thereof.

 

 

 

    	 	6	 

     

    

 

Section
5.03 Waivers. The Company and all others who are, or may become liable for the payment hereof: (i) severally waive presentment
for payment, demand, notice of nonpayment or dishonor, protest and notice of protest of this Debenture or any other Transaction
Documents, and all other notices in connection with the delivery, acceptance, performance, default, or enforcement of the payment
of this Debenture and the other Transaction Documents, except as specifically provided in this Debenture or any other Transaction
Document; (ii) expressly consent to all extensions of time, renewals or postponements of time of payment of this Debenture and
any other Transaction Documents from time to time prior to or after the maturity of this Debenture without notice, consent or further
consideration to any of the foregoing; (iii) expressly agree that the Holder shall not be required first to institute any suit,
or to exhaust its remedies against the Company or any other person or party to become liable hereunder or against any collateral
that may secure this Debenture in order to enforce the payment of this Debenture; and (iv) expressly agree that, notwithstanding
the occurrence of any of the foregoing (except the express written release by the Holder of any such person), the undersigned shall
be and remain, directly and primarily liable for all sums due under this Debenture.

 

Section
5.04 No Waiver. Holder shall not be deemed, by any act of omission or commission, to have waived any of its rights or remedies
hereunder unless such waiver is in writing and signed by Holder, and then only to the extent specifically set forth in the writing.
A waiver on one event shall not be construed as continuing or as a bar to or waiver of any right or remedy to a subsequent event.

 

ARTICLE VI

 

Section
6.01 Notice. Any notices, consents, waivers, or other communications required or permitted to be given under the terms of
this Debenture must be in writing and in each case properly addressed to the party to receive the same in accordance with the information
below, and will be deemed to have been delivered: (i) if mailed by certified mail, return receipt requested, postage prepaid and
properly addressed to the address below, then three (3) business days after deposit of same in a regularly maintained U.S. Mail
receptacle; or (ii) if mailed by Federal Express, UPS or other nationally recognized overnight courier service, next business morning
delivery, then one (1) business day after deposit of same in a regularly maintained receptacle of such overnight courier; or (iii)
if hand delivered, then upon hand delivery thereof to the address indicated on or prior to 5:00 p.m ., EST, on a business day.
Any notice hand delivered after 5:00 p.m., EST, shall be deemed delivered on the following business day. Notwithstanding the foregoing,
notice, consents, waivers or other communications referred to in this Debenture may be sent by facsimile, e-mail, or other method
of delivery, but shall be deemed to have been delivered only when the sending party has confirmed (by reply e-mail or some other
form of written confirmation from the receiving party) that the notice has been received by the other party. The addresses and
facsimile numbers for such communications shall be as set forth below, unless such address or information is changed by a notice
conforming to the requirements hereof.

 

    	 	7	 

     

    

 

 

	 	If to the Company:	 	Medytox Solutions, Inc.
	 	 	 	400 South Australian Avenue, 8th Floor
	 	 	 	West Palm Beach, FL 33401
	 	 	 	Attention:  Jace Simmons 
	 	 	 	E-Mail:  jsimmons@medytoxsolutionsinc.com
	 	 	 	 
	 	With a copy to:	 	Akerman LLP 
	 	(which shall not constitute notice)	 	One Southeast Third Avenue 
	 	 	 	Miami, FL 33131 
	 	 	 	Attention: Dean M. Freitag, Esq. 
	 	 	 	E-Mail:  dean.freitag@akerman.com 
	 	 	 	 
	 	If to the Holder:	 	TCA Global Credit Master Fund, LP 
	 	 	 	3960 Howard Hughes Parkway, Suite 500
	 	 	 	Las Vegas, NV 89196
	 	 	 	Attn: Mr. Robert Press
	 	 	 	E-Mail:  bpress@tcaglobalfund.com
	 	 	 	 
	 	With a copy to:	 	Lucosky Brookman LLP
	 	(which shall not constitute notice)	 	101 Wood Avenue South, 5th Floor 
	 	 	 	Woodbridge, NJ 08830
	 	 	 	Attn: Seth A. Brookman, Esq. 
	 	 	 	E-Mail:  sbrookman@lucbro.com

 

Section
6.02 Governing Law and Venue. The Company and Holder each irrevocably agrees that any dispute arising under, relating to,
or in connection with, directly or indirectly, this Debenture or related to any matter which is the subject of or incidental to
this Debenture (whether or not such claim is based upon breach of contract or tort) shall be subject to the exclusive jurisdiction
and venue of the state and/or federal courts located in Broward County, Florida. This provision is intended to be a “mandatory”
forum selection clause and governed by and interpreted consistent with Florida law. The Company and Holder each hereby consents
to the exclusive jurisdiction and venue of any state or federal court having its situs in said county, and each waives any objection
based on forum non conveniens. The Company hereby waives personal service of any and all process and consent that all such service
of process may be made by certified mail, return receipt requested, directed to the Company, as set forth herein in the manner
provided by applicable statute, law, rule of court or otherwise. Except for the foregoing mandatory forum selection clause, all
terms and provisions hereof and the rights and obligations of the Company and Holder hereunder shall be governed, construed and
interpreted in accordance with the laws of the State of Nevada, without reference to conflict of laws principles.

 

Section 6.03 Severability.
In the event any one or more of the provisions of this Debenture shall for any reason be held to be invalid, illegal, or unenforceable,
in whole or in part, in any respect, or in the event that any one or more of the provisions of this Debenture operates or would
prospectively operate to invalidate this Debenture, then and in any of those events, only such provision or provisions shall be
deemed null and void and shall not affect any other provision of this Debenture. The remaining provisions of this Debenture shall
remain operative and in full force and effect and shall in no way be affected, prejudiced, or disturbed thereby.

 

 

    	 	8	 

     

    

 

Section 6.04 Entire
Agreement and Amendments. This Debenture, together with the other Transaction Documents represents the entire agreement between
the parties hereto with respect to the subject matter hereof and thereof, and there are no representations, warranties or commitments,
except as set forth herein and therein. This Debenture may be amended only by an instrument in writing executed by the parties
hereto.

 

Section 6.05 Binding
Effect. This Debenture shall be binding upon the Company and the successors and assigns of the Company and shall inure to the
benefit of the Holder and the successors and assigns of the Holder.

 

Section 6.06 Assignment.
The Holder may from time to time sell or assign, in whole or in part, or grant participations in, this Debenture and/or the obligations
evidenced hereby without the consent of the Company. The holder of any such sale, assignment or participation, if the applicable
agreement between Holder and such holder so provides, shall be: (i) entitled to all of the rights obligations and benefits of Holder
(to the extent of such holder’s interest or pa1ticipation); and (ii) deemed to hold and may exercise the rights of setoff
or banker’s lien with respect to any and all obligations of such holder to the Company (to the extent of such holder s interest
or participation), in each case as fully as though the Company was directly indebted to such holder. Holder may in its discretion
give notice to the Company of such sale, assignment or participation; however, the failure to give such notice shall not affect
any of Holder’s or such holder’s rights hereunder.

 

Section 6.07 Lost
or Mutilated Debenture. If this Debenture shall be mutilated, lost, stolen or destroyed the Company shall execute and
deliver, in exchange and substitution for and upon cancellation of a mutilated Debenture or in lieu of or in substitution for
a lost, stolen or destroyed Debenture a new Debenture for the principal amount of this Debenture so mutilated, lost stolen or
destroyed, but only upon receipt of evidence of such loss, theft or destruction of such Debenture, and of the ownership
hereof, reasonably satisfactory to the Company.

 

Section
6.08 WAIVER OF JURY TRIAL. THE COMPANY HEREBY KNOWINGLY, VOLUNTARILY, INTENTIONALLY AND IRREVOCABLY WAIVES ALL RIGHT TO
A TRIAL BY JURY WITH RESPECT TO ANY LITIGATION BASED ON THIS DEBENTURE, OR ARISING OUT OF, UNDER OR IN CONNECTION WITH, THIS DEBENTURE
OR ANY OTHER TRANSACTION DOCUMENTS, OR ANY COURSE OF CONDUCT, COURSE OF DEALING, STATEMENTS (WHETHER VERBAL OR WRITTEN) OR ACTIONS
OF OR BETWEEN ANY PARTY HERETO, AND THE COMPANY AGREES AND CONSENTS TO THE GRANTING TO HOLDER OF RELIEF FROM ANY STAY ORDER WHICH
MIGHT BE ENTERED BY ANY COURT AGAINST HOLDER AND TO ASSIST HOLDER IN OBTAINING SUCH RELIEF. THIS PROVISION IS A MATERIAL INDUCEMENT
FOR HOLDER ACCEPTING THIS DEBENTURE FROM THE COMPANY. THE COMPANY’S REASONABLE RELIANCE UPON SUCH INDUCEMENT IS HEREBY ACKNOWLEDGED.

 

 

    	 	9	 

     

    

 

Section
6.09 NON-US STATUS. THE HOLDER IS A NON-US PERSON AS THAT TERM IS DEFINED IN THE UNITED STATES INTERNAL REVENUE CODE. IT
IS HEREBY AGREED AND UNDERSTOOD THAT THE OBLIGATIONS HEREUNDER MAY BE SOLD ONLY TO NON-U.S. PERSON. THE INTEREST PAYABLE HEREUNDER
IS PAYABLE ONLY OUTSIDE THE UNITED STATES. ANY U.S. PERSON WHO HOLDS THIS OBLIGATION WILL BE SUBJECT TO LIMITATIONS UNDER THE UNITED
STATES INCOME TAX LAW. BY ACCEPTING THIS OBLIGATION, THE HOLDER REPRESENTS AND WARRANT THAT IT IS NOT A UNITED STATES PERSON (OTHER
THAN AN EXEMPT RECIPIENT DESCRIBED IN SECTION 6049(8)(4) OF THE INTERNAL REVENUE CODE AND REGULATIONS THEREUNDER) AND THAT IT IS
NOT ACTING FOR OR ON BEHALF OF A UNITED STATE PERSON (OTHER THAN AN EXEMPT RECIPIENT DESCRIBED IN SECTION 6049(B)(4) OF THE INTERNAL
REVENUE CODE AND THE REGULATIONS THEREUNDER).

 

ARTICLE VII

 

Section
7.01 Conversion of Debenture. At any time and from time to time while this Debenture is outstanding on or after the Closing
Date, (i) if mutually agreed upon by the parties or (ii) upon the occurrence of an Event of Default at the sole option of the Holder,
this Debenture may be, convertible into shares of the Company’s common stock, $0.0001 par
value per share (the “Common Stock”) in accordance with the terms and conditions set forth in this Article VII.

 

(1)               
Voluntary Conversion. At any time while this Debenture is outstanding on or
after the Closing Date, (i) if mutually agreed upon by the parties or (ii) at the sole option of the Holder by delivery of a Conversion
Notice (as defined below) to the Company no later than ten (10) days following the occurrence of an Event of Default (the “Conversion
Window”), the Holder may convert all or any portion of the outstanding principal, accrued and unpaid interest (but without
giving effect to any default rate of interest), and any other sums due and payable hereunder or under any of the other Transaction
Documents (such total amount, the “Conversion Amount”) into shares of Common Stock of the Company (the “Conversion
Shares”) at a price equal to: (i) the Conversion Amount (the numerator); divided by (ii) eighty-five percent (85%)
of the lowest of the volume weighted average price of the Company’s Common Stock during the five (5) trading days immediately
prior to the Conversion Date (as defined below), as indicated in the conversion notice (in the form attached hereto as Exhibit
“B” the “Conversion Notice”) (the denominator) (the “Conversion Price”). The
Holder shall submit a Conversion Notice indicating the amount of the Debenture being converted and the number of Conversion Shares
issuable upon such conversion as calculated by it in good faith, and where the Conversion Shares should be delivered. For avoidance
of doubt, any Conversion Shares issued to Holder pursuant to this Section 7.01 will not be registered under the Securities Act
of 1933, as amended, or pursuant to the laws of any State.

 

 

 

    	 	10	 

     

    

 

(2)               
The Holder’s Conversion Limitations. The Company shall not affect any
conversion of this Debenture, and the Holder shall not have the right to convert any portion of this Debenture, to the extent that
after giving effect to the conversion set forth on the Conversion Notice submitted by the Holder, the Holder (together with the
Holder’s affiliates (as defined herein) and any Persons acting as a group together with the Holder or any of the Holder’s
affiliates) would beneficially own in excess of the Beneficial Ownership Limitation (as defined herein). To ensure compliance with
this restriction, prior to delivery of any Conversion Notice, the Holder shall have the right to request that the Company provide
to the Holder a written statement of the percentage ownership of the Company’s Common Stock that would by beneficially owned
by the Holder and its affiliates in the Company if the Holder converted such portion of this Debenture then intended to be converted
by Holder. The Company shall, within two (2) business days of such request, provide Holder with the requested information in a
written statement, and the Holder shall be entitled to rely on such written statement from the Company in issuing its Conversion
Notice and ensuring that its ownership of the Company’s Common Stock is not in excess of the Beneficial Ownership Limitation.
The restriction described in this Section may be waived by Holder, in whole or in part, upon notice from the Holder to the Company.
In addition, the Company shall not have any obligation to effect any conversion of this Debenture to the extent that after giving
effect to any such conversion the Holder (together with the Holder’s affiliates and any Persons acting as a group with the
Holder or any of the Holder’s affiliates) would beneficially own in excess of 9.99% of the outstanding shares of Common Stock
after giving effect to any such conversion. for purposes of this Debenture, the “Beneficial Ownership Limitation”
shall be 4.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of
Common Stock issuable upon conversion of this Debenture. The limitations contained in this Section shall apply to any successor
holder of this Debenture. For purposes of this Debenture, “Person” means an individual, a limited liability
company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization or a government or any department
or agency thereof.

 

(3)                     
Mechanics of Conversion.The conversion of this Debenture shall be conducted
in the following manner:

 

(a)            
Holder’s Delivery Requirements. To convert this Debenture into shares
of Common Stock on any date (during the Conversion Window, in the case of any conversions following an Event of Default) set forth
in the Conversion Notice by the Holder (the “Conversion Date”), the Holder shall transmit by facsimile or electronic
mail (or otherwise deliver) a copy of the fully executed Conversion Notice to the Company (or, under certain circumstances as set
forth below, by delivery of the Conversion Notice to the Company’s transfer agent).

 

 

    	 	11	 

     

    

 

(b)           
Company’s Response. Upon timely receipt by the Company of a copy of a
Conversion Notice, the Company shall as soon as practicable, but in no event later than two (2) Business Days after receipt of
such Conversion Notice, send, via facsimile or electronic mail (or otherwise deliver) a confirmation of receipt of such Conversion
Notice (the “Conversion Confirmation”) to the Holder indicating that the Company will process such Conversion
Notice in accordance with the terms herein. In the event the Company fails to issue its Conversion Confirmation within said two
(2) Business Day time period, the Holder shall have the absolute and irrevocable right and authority to deliver the fully executed
Conversion Notice to the Company’s transfer agent, and pursuant to the terms of the Purchase Agreement, the Company’s
transfer agent shall issue the applicable Conversion Shares to Holder as hereby provided. Within five (5) Business Days after the
date of the Conversion Confirmation (or the date of the Conversion Notice, if the Company fails to issue the Conversion Confirmation),
provided that the Company’s transfer agent is participating in the Depository Trust Company (“DTC”) Fast
Automated Securities Transfer (“FAST”) program, the Company shall cause the transfer agent to (or, if for any
reason the Company fails to instruct or cause its transfer agent to so act, then pursuant to the Purchase Agreement, the Holder
may request and require the Company’s transfer agent to) electronically transmit the applicable Conversion Shares to which
the Holder shall be entitled by crediting the account of the Holder’s prime broker with DTC through its Deposit Withdrawal
Agent Commission (“DWAC”) system, and provide proof satisfactory to the Holder of such delivery. In the event
that the Company’s transfer agent is not participating in the DTC FAST program and is not otherwise DWAC eligible (or in
the event the Holder otherwise requests), within five (5) Business Days after the date of the Conversion Confirmation (or the date
of the Conversion Notice, if the Company fails to issue the Conversion Confirmation), the Company shall instruct and cause its
transfer agent to (or, if for any reason the Company fails to instruct or cause its transfer agent to so act, then pursuant to
the Purchase Agreement, the Holder may request and require the Company’s transfer agent to) issue and surrender to a nationally
recognized overnight courier for delivery to the address specified in the Conversion Notice, a certificate, registered in the name
of the Holder or its nominee, for the number of Conversion Shares to which the Holder shall be entitled. To effect conversions
hereunder, the Holder shall not be required to physically surrender this Debenture to the Company unless the entire principal amount
of this Debenture, plus all accrued and unpaid interest thereon and other sums due hereunder, has been so converted. Conversions
hereunder shall have the effect of lowering the outstanding principal amount of this Debenture in an amount equal to the applicable
Conversion Amount. The Holder and the Company shall maintain records showing the principal amount(s) converted and the date of
such conversion(s). The Holder, and any assignee by acceptance of this Debenture, acknowledge and agree that, by reason of the
provisions of this paragraph, following conversion of a portion of this Debenture, the unpaid and unconverted principal amount
of this Debenture may be less than the amount stated on the face hereof.

 

(c)             
Record Holder. The Person(s) entitled to receive the shares of Common Stock
issuable upon a conversion of this Debenture shall be treated for all purposes as the record holder(s) of such shares of Common
Stock as of the Conversion Date.

 

(d)               
Failure to Deliver Certificates. If in the case of any Conversion Notice, the certificate or certificates are not
delivered to or as directed by the Holder by the date required hereby, the Holder shall be entitled to elect by written notice
to the Company at any time on or before its receipt of such certificate or certificates, to rescind such Conversion Notice, in
which event the Company shall promptly return to the Holder any original Debenture delivered to the Company and the Holder shall
promptly return to the Company the Common Stock certificates representing the principal amount of this Debenture unsuccessfully
tendered for conversion to the Company.

 

 

    	 	12	 

     

    

 

(e)             
Obligation Absolute; Partial Liquidated Damages. The Company’s obligations
to issue and deliver the Conversion Shares upon conversion of this Debenture in accordance with the terms hereof are absolute and
unconditional, irrespective of any action or inaction by the Holder to enforce the same, any waiver or consent with respect to
any provision hereof, the recovery of any judgment against any person or entity or any action to enforce the same, or any setoff,
counterclaim, recoupment, limitation or termination, or any breach or alleged breach by the Holder or any other person or entity
of any obligation to the Company or any violation or alleged violation of law by the Holder or any other person or entity, and
irrespective of any other circumstance which might otherwise limit such obligation of the Company to the Holder in connection with
the issuance of such Conversion Shares; provided, however, that such delivery shall not operate as a waiver by the Company of any
such action the Company may have against the Holder . In the event the Holder of this Debenture shall elect to convert any or all
of the outstanding principal amount hereof and accrued but unpaid interest thereon in accordance with the terms of this Debenture,
the Company may not refuse conversion based on any claim that the Holder or anyone associated or affiliated with the Holder has
been engaged in any violation of law, agreement or for any other reason, unless an injunction from a court, on notice to Holder,
restraining and or enjoining conversion of all or part of this Debenture shall have been sought and obtained, and the Company posts
a surety bond for the benefit of the Holder in the amount of 150% of the outstanding principal amount of this Debenture being converted,
which is subject to the injunction, which bond shall remain in effect until the completion of arbitration/litigation of the underlying
dispute and the proceeds of which shall be payable to such Holder to the extent it obtains judgment. In the absence of such injunction,
the Company shall issue Conversion Shares upon a properly noticed conversion. If the Company fails for any reason to deliver to
the Holder such certificate or certificates representing Conversion Shares pursuant to timing and delivery requirements of this
Debenture, the Company shall pay to such Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of principal
amount being converted, $1.00 per day for each day after the date by which such certificates should have been delivered until such
certificates are delivered. Nothing herein shall limit a Holder’s right to pursue actual damages or declare an Event of Default
pursuant to this Debenture or any agreement securing the indebtedness under this Debenture for the Company’s failure to deliver
Conversion Shares within the period specified herein and such Holder shall have the right to pursue all remedies available to it
hereunder, at law or in equity, including, without limitation, a decree of specific performance and/or injunctive relief. The exercise
of any such rights shall not prohibit the Holder from seeking to enforce damages pursuant to any other Section hereof or under
applicable law. Nothing herein shall prevent the Holder from having the Conversion Shares issued directly by the Company’s
transfer agent in accordance with the Purchase Agreement, in the event for any reason the Company fails to issue or deliver, or
cause its transfer agent to issue and deliver, the Conversion Shares to the Holder upon exercise of Holder’s conversion rights
hereunder.

 

(f)         
Transfer Taxes. The issuance of certificates for shares of the Common Stock
on conversion of this Debenture shall be made without charge to the Holder hereof for any documentary stamp or similar taxes, or
any other issuance or transfer fees of any nature or kind that may be payable in respect of the issue or delivery of such certificates,
any such taxes or fees, if payable, to be paid by the Company.

 

(4)                   
Reservation of Common Stock. If upon receipt of a Conversion Notice from the
Holder, the Share Reserve is insufficient to effect the full conversion of the Debenture then outstanding, the Company shall use
reasonable best efforts to cause the Share Reserve to be increased accordingly within forty-five (45) days to an amount of shares
equal to three (3) times the Conversion Shares. The Company’s management shall recommend to the shareholders to vote in favor
of increasing the number of shares of Common Stock authorized.

 

 

    	 	13	 

     

    

 

(5)                   
Make-Whole Rights. Upon liquidation by the Holder of Conversion Shares issued
pursuant to a Conversion Notice, provided that the Holder realizes a net amount from such liquidation equal to less than the Conversion
Amount specified in the relevant Conversion Notice (such net realized amount, the “Realized Amount”), the Company
shall issue to the Holder additional shares of the Company’s Common Stock equal to: (i) the Conversion Amount specified in
the relevant Conversion Notice; minus (ii) the Realized Amount, as evidenced by a reconciliation statement from the Holder
(a “Sale Reconciliation”) showing the Realized Amount from the sale of the Conversion Shares; divided by
(iii) the average volume weighted average price of the Company’s Common Stock during the five (5) Business Days immediately
prior to the date upon which the Holder delivers notice (the “Make-Whole Notice”) to the Company that such additional
shares are requested by the Holder (the “Make-Whole Stock Price”) (such number of additional shares to be issued,
the “Make-Whole Shares”). Upon receiving the Make-Whole Notice and Sale Reconciliation evidencing the number
of Make-Whole Shares requested, the Company shall instruct its transfer agent to issue certificates representing the Make-Whole
Shares, which Make-Whole Shares shall be issued and delivered in the same manner and within the same time frames as set forth herein.
The Make-Whole Shares, when issued, shall be deemed to be validly issued, fully paid, and non-assessable shares of the Company’s
Common Stock. Following the sale of the Make-Whole Shares by the Holder: (i) in the event that the Holder receives net proceeds
from such sale which, when added to the Realized Amount from the prior relevant Conversion Notice, is less than the Conversion
Amount specified in the relevant Conversion Notice, the Holder shall deliver an additional Make-Whole Notice to the Company following
the procedures provided previously in this paragraph, and such procedures and the delivery of Make-Whole Notices and issuance of
Make-Whole Shares shall continue until the Conversion Amount has been fully satisfied; and (ii) in the event that the Holder received
net proceeds from the sale of Make-Whole Shares in excess of the Conversion Amount specified in the relevant Conversion Notice,
such excess amount shall be applied to satisfy any and all amounts owed hereunder in excess of the Conversion Amount specified
in the relevant Conversion Notice.

 

(6)                   
Adjustments to Conversion Price.

 

(a)  
Notice to Allow Conversion by Holder. If (A) the Company shall declare a dividend
(or any other distribution in whatever form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend
on or a redemption of the Common Stock, (C) the Company shall authorize the granting to all holders of the Common Stock of rights
or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders
of the Company shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which
the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, of any compulsory share
exchange whereby the Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the
voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company
shall cause to be filed at each office or agency maintained for the purpose of conversion of this Debenture, and shall cause to
be delivered to the Holder at its last address as it shall appear upon the Company’s records, at least twenty (20) calendar
days prior to the applicable record or effective date hereinafter specified, a notice stating: (x) the date on which a record is
to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken,
the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights
or warrants are to be determined, or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share
exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of
record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such
reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date
as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common
Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share
exchange, provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the
validity of the corporate action required to be specified in such notice.

 

[signature page follows]

 

 

    	 	14	 

     

    

 

IN WITNESS
WHEREOF with the intent to be legally bound hereby, the Company as executed this Senior Secured, Convertible, Redeemable Debenture
as of the date first written above.

 

MEDYTOX SOLUTIONS, INC.

 

By: /s/ Seamus Lagan

Name: Seamus Lagan

Title: Chief Executive Officer

 

	STATE OF ________________	)
	 	) SS.
	COUNTY OF ______________	)

 

The undersigned, a
Notary Public in and for the said County, in the State aforesaid, DO HEREBY CERTIFY that Seamus Lagan, the Chief Executive Officer
of Medytox Solutions, Inc., a Nevada corporation, who is personally known to me to be the same person whose name is subscribed
to the foregoing instrument, appeared before me this day in person and acknowledged that he/she signed and delivered the said instrument
as his/her own free and voluntary act and as the free and voluntary act of said corporation, for the uses and purposes therein
set forth.

 

GIVEN under my hand and notarial seal this
_____ day of ________________, 20____.

 

 

	 	 
	 	Notary Public
	 	 
	 	My Commission Expires:
	 	 
	 	 

 

 

    	 	15	 

     

    

 

CONSENT AND AGREEMENT

 

The undersigned is a Guarantor, as that
term is defined in that certain securities purchase agreement by and between the Company and the Holder and, as such, the undersigned
hereby consents and agrees to the payment of the amounts contemplated in the senior secured, convertible, redeemable debenture,
documents contemplated thereby and to the provisions contained therein relating to conditions to be fulfilled and obligations to
be performed by the Company pursuant to or in connection with said senior secured, convertible, redeemable debenture to the same
extent as if the undersigned were a party to said senior secured, convertible, redeemable debenture.

 

GUARANTOR:

 

MEDYTOX INFORMATION TECHNOLOGY, INC.

 

 

By:/s/ Seamus Lagan

Name: Seamus Lagan

Title: Chief Executive Officer

 

	STATE OF ________________	)
	 	) SS.
	COUNTY OF ______________	)

 

The undersigned, a
Notary Public in and for the said County, in the State aforesaid, DO HEREBY CERTIFY that Seamus Lagan, the Chief Executive Officer
of Medytox Information Technology, Inc., a Florida corporation, who is personally known to me to be the same person whose name
is subscribed to the foregoing instrument, appeared before me this day in person and acknowledged that he/she signed and delivered
the said instrument as his/her own free and voluntary act and as the free and voluntary act of said corporation, for the uses and
purposes therein set forth.

 

GIVEN under my hand and notarial seal this
_____ day of ________________, 20____.

 

	 	 
	 	Notary Public
	 	 
	 	My Commission Expires:
	 	 
	 	 

 

 

    	 	16	 

     

    

 

CONSENT AND AGREEMENT

 

The undersigned is a Guarantor, as that
term is defined in that certain securities purchase agreement by and between the Company and the Holder and, as such, the undersigned
hereby consents and agrees to the payment of the amounts contemplated in the senior secured, convertible, redeemable debenture,
documents contemplated thereby and to the provisions contained therein relating to conditions to be fulfilled and obligations to
be performed by the Company pursuant to or in connection with said senior secured, convertible, redeemable debenture to the same
extent as if the undersigned were a party to said senior secured, convertible, redeemable debenture.

 

GUARANTOR:

 

 

MEDYTOX INSTITUTE OF LABORATORY MEDICINE, INC.

 

By:/s/ Seamus Lagan

Name: Seamus Lagan

Title: Chief Executive Officer

 

 

	STATE OF ________________	)
	 	) SS.
	COUNTY OF ______________	)

 

The undersigned, a
Notary Public in and for the said County, in the State aforesaid, DO HEREBY CERTIFY that Seamus Lagan, the Chief Executive Officer
of Medytox Institute of Laboratory Medicine, Inc., a Florida corporation, who is personally known to me to be the same person whose
name is subscribed to the foregoing instrument, appeared before me this day in person and acknowledged that he/she signed and delivered
the said instrument as his/her own free and voluntary act and as the free and voluntary act of said corporation, for the uses and
purposes therein set forth.

 

GIVEN under my hand and notarial seal this
_____ day of ________________, 20____.

 

 

	 	 
	 	Notary Public
	 	 
	 	My Commission Expires:
	 	 
	 	 

 

    	 	17	 

     

    

 

CONSENT AND AGREEMENT

 

The undersigned is a Guarantor, as that
term is defined in that certain securities purchase agreement by and between the Company and the Holder and, as such, the undersigned
hereby consents and agrees to the payment of the amounts contemplated in the senior secured, convertible, redeemable debenture,
documents contemplated thereby and to the provisions contained therein relating to conditions to be fulfilled and obligations to
be performed by the Company pursuant to or in connection with said senior secured, convertible, redeemable debenture to the same
extent as if the undersigned were a party to said senior secured, convertible, redeemable debenture.

 

GUARANTOR:

 

MEDICAL BILLING CHOICES INC.

 

 

By:/s/ Seamus Lagan

Name: Seamus Lagan

Title:President

 

	STATE OF ________________	)
	 	) SS.
	COUNTY OF ______________	)

 

The undersigned, a
Notary Public in and for the said County, in the State aforesaid, DO HEREBY CERTIFY that Seamus Lagan, the President of Medical
Billing Choices Inc., a North Carolina corporation, who is personally known to me to be the same person whose name is subscribed
to the foregoing instrument, appeared before me this day in person and acknowledged that he/she signed and delivered the said instrument
as his/her own free and voluntary act and as the free and voluntary act of said corporation, for the uses and purposes therein
set forth.

 

GIVEN under my hand and notarial seal this
_____ day of ________________, 20____.

 

	 	 
	 	Notary Public
	 	 
	 	My Commission Expires:
	 	 
	 	 

 

 

    	 	18	 

     

    

 

CONSENT AND AGREEMENT

 

The undersigned is a Guarantor, as that
term is defined in that certain securities purchase agreement by and between the Company and the Holder and, as such, the undersigned
hereby consents and agrees to the payment of the amounts contemplated in the senior secured, convertible, redeemable debenture,
documents contemplated thereby and to the provisions contained therein relating to conditions to be fulfilled and obligations to
be performed by the Company pursuant to or in connection with said senior secured, convertible, redeemable debenture to the same
extent as if the undersigned were a party to said senior secured, convertible, redeemable debenture.

 

GUARANTOR:

 

MEDYTOX DIAGNOSTICS, INC.

 

 

By:/s/ Seamus Lagan

Name: Seamus Lagan

Title:Chief Executive Officer

 

	STATE OF ________________	)
	 	) SS.
	COUNTY OF ______________	)

 

The undersigned, a
Notary Public in and for the said County, in the State aforesaid, DO HEREBY CERTIFY that Seamus Lagan, the Chief Executive Officer
of Medytox Diagnostics, Inc., a Florida corporation, who is personally known to me to be the same person whose name is subscribed
to the foregoing instrument, appeared before me this day in person and acknowledged that he/she signed and delivered the said instrument
as his/her own free and voluntary act and as the free and voluntary act of said corporation, for the uses and purposes therein
set forth.

 

GIVEN under my hand and notarial seal this
_____ day of ________________, 20____.

 

	 	 
	 	Notary Public
	 	 
	 	My Commission Expires:
	 	 
	 	 

 

 

 

 

    	 	19	 

     

    

 

CONSENT AND AGREEMENT

 

The undersigned is a Guarantor, as that
term is defined in that certain securities purchase agreement by and between the Company and the Holder and, as such, the undersigned
hereby consents and agrees to the payment of the amounts contemplated in the senior secured, convertible, redeemable debenture,
documents contemplated thereby and to the provisions contained therein relating to conditions to be fulfilled and obligations to
be performed by the Company pursuant to or in connection with said senior secured, convertible, redeemable debenture to the same
extent as if the undersigned were a party to said senior secured, convertible, redeemable debenture.

 

GUARANTOR:

 

MEDYTOX MEDICAL MARKETING & SALES, INC.

 

 

By:/s/ Seamus Lagan

Name: Seamus Lagan

Title:Chief Executive Officer

 

	STATE OF ________________	)
	 	) SS.
	COUNTY OF ______________	)

 

 

The undersigned, a
Notary Public in and for the said County, in the State aforesaid, DO HEREBY CERTIFY that Seamus Lagan, the Chief Executive Officer
of Medytox Medical Marketing & Sales, Inc., a Florida corporation, who is personally known to me to be the same person whose
name is subscribed to the foregoing instrument, appeared before me this day in person and acknowledged that he/she signed and delivered
the said instrument as his/her own free and voluntary act and as the free and voluntary act of said corporation, for the uses and
purposes therein set forth.

 

GIVEN under my hand and notarial seal this
_____ day of ________________, 20____.

 

	 	 
	 	Notary Public
	 	 
	 	My Commission Expires:
	 	 
	 	 

 

 

 

 

 

    	 	20	 

     

    

 

CONSENT AND AGREEMENT

 

The undersigned is a Guarantor, as that
term is defined in that certain securities purchase agreement by and between the Company and the Holder and, as such, the undersigned
hereby consents and agrees to the payment of the amounts contemplated in the senior secured, convertible, redeemable debenture,
documents contemplated thereby and to the provisions contained therein relating to conditions to be fulfilled and obligations to
be performed by the Company pursuant to or in connection with said senior secured, convertible, redeemable debenture to the same
extent as if the undersigned were a party to said senior secured, convertible, redeemable debenture.

 

GUARANTOR:

 

PB LABORATORIES, LLC

 

 

By:/s/ NormaVillar

Name: Norma Villar

Title:Chief Financial Officer

 

	STATE OF ________________	)
	 	) SS.
	COUNTY OF ______________	)

 

The undersigned, a
Notary Public in and for the said County, in the State aforesaid, DO HEREBY CERTIFY that Norma Villar, the Chief Financial Officer
of PB Laboratories, LLC, a Florida limited liability company, who is personally known to me to be the same person whose name is
subscribed to the foregoing instrument, appeared before me this day in person and acknowledged that he/she signed and delivered
the said instrument as his/her own free and voluntary act and as the free and voluntary act of said corporation, for the uses and
purposes therein set forth.

 

GIVEN under my hand and notarial seal this
_____ day of ________________, 20____.

 

	 	 
	 	Notary Public
	 	 
	 	My Commission Expires:
	 	 
	 	 

 

 

 

    	 	21	 

     

    

 

 

CONSENT AND AGREEMENT

 

The undersigned is a Guarantor, as that
term is defined in that certain securities purchase agreement by and between the Company and the Holder and, as such, the undersigned
hereby consents and agrees to the payment of the amounts contemplated in the senior secured, convertible, redeemable debenture,
documents contemplated thereby and to the provisions contained therein relating to conditions to be fulfilled and obligations to
be performed by the Company pursuant to or in connection with said senior secured, convertible, redeemable debenture to the same
extent as if the undersigned were a party to said senior secured, convertible, redeemable debenture.

 

GUARANTOR:

 

BIOHEALTH MEDICAL LABORATORY, INC.

 

 

By:/s/ NormaVillar

Name: Norma Villar

Title:Chief Financial Officer

 

 

	STATE OF ________________	)
	 	) SS.
	COUNTY OF ______________	)

 

The undersigned, a
Notary Public in and for the said County, in the State aforesaid, DO HEREBY CERTIFY that Norma Villar, the Chief Financial Officer
of Biohealth Medical Laboratory Inc., a Florida corporation, who is personally known to me to be the same person whose name is
subscribed to the foregoing instrument, appeared before me this day in person and acknowledged that he/she signed and delivered
the said instrument as his/her own free and voluntary act and as the free and voluntary act of said corporation, for the uses and
purposes therein set forth.

 

GIVEN under my hand and notarial seal this
_____ day of ________________, 20____.

 

	 	 
	 	Notary Public
	 	 
	 	My Commission Expires:
	 	 
	 	 

 

 

 

 

    	 	22	 

     

    

 

CONSENT AND AGREEMENT

 

The undersigned is a Guarantor, as that
term is defined in that certain securities purchase agreement by and between the Company and the Holder and, as such, the undersigned
hereby consents and agrees to the payment of the amounts contemplated in the senior secured, convertible, redeemable debenture,
documents contemplated thereby and to the provisions contained therein relating to conditions to be fulfilled and obligations to
be performed by the Company pursuant to or in connection with said senior secured, convertible, redeemable debenture to the same
extent as if the undersigned were a party to said senior secured, convertible, redeemable debenture.

 

GUARANTOR:

 

ALETHEA LABORATORIES, INC.

 

 

By:/s/ NormaVillar

Name: Norma Villar

Title:Chief Financial Officer

 

	STATE OF ________________	)
	 	) SS.
	COUNTY OF ______________	)

 

 

The undersigned, a
Notary Public in and for the said County, in the State aforesaid, DO HEREBY CERTIFY that Norma Villar, the Chief Financial Officer
of Alethea Laboratories, Inc., a Texas corporation, who is personally known to me to be the same person whose name is subscribed
to the foregoing instrument, appeared before me this day in person and acknowledged that he/she signed and delivered the said instrument
as his/her own free and voluntary act and as the free and voluntary act of said corporation, for the uses and purposes therein
set forth.

 

GIVEN under my hand and notarial seal this
_____ day of ________________, 20____.

 

	 	 
	 	Notary Public
	 	 
	 	My Commission Expires:
	 	 
	 	 

 

 

 

    	 	23	 

     

    

 

 

CONSENT AND AGREEMENT

 

The undersigned is a Guarantor, as that
term is defined in that certain securities purchase agreement by and between the Company and the Holder and, as such, the undersigned
hereby consents and agrees to the payment of the amounts contemplated in the senior secured, convertible, redeemable debenture,
documents contemplated thereby and to the provisions contained therein relating to conditions to be fulfilled and obligations to
be performed by the Company pursuant to or in connection with said senior secured, convertible, redeemable debenture to the same
extent as if the undersigned were a party to said senior secured, convertible, redeemable debenture.

 

GUARANTOR:

 

INTERNATIONAL TECHNOLOGIES, LLC

 

 

By:/s/ Dr. William DePond

Name: Dr. William DePond

Title:Manager

 

	STATE OF ________________	)
	 	) SS.
	COUNTY OF ______________	)

 

 

The undersigned, a
Notary Public in and for the said County, in the State aforesaid, DO HEREBY CERTIFY that Dr. William DePond, the Manager of International
Technologies, LLC, a New Jersey limited liability company, who is personally known to me to be the same person whose name is subscribed
to the foregoing instrument, appeared before me this day in person and acknowledged that he/she signed and delivered the said instrument
as his/her own free and voluntary act and as the free and voluntary act of said corporation, for the uses and purposes therein
set forth.

 

GIVEN under my hand and notarial seal this
_____ day of ________________, 20____.

 

	 	 
	 	Notary Public
	 	 
	 	My Commission Expires:
	 	 
	 	 

 

 

 

 

    	 	24	 

     

    

 

CONSENT AND AGREEMENT

 

The undersigned is a Guarantor, as that
term is defined in that certain securities purchase agreement by and between the Company and the Holder and, as such, the undersigned
hereby consents and agrees to the payment of the amounts contemplated in the senior secured, convertible, redeemable debenture,
documents contemplated thereby and to the provisions contained therein relating to conditions to be fulfilled and obligations to
be performed by the Company pursuant to or in connection with said senior secured, convertible, redeemable debenture to the same
extent as if the undersigned were a party to said senior secured, convertible, redeemable debenture.

 

GUARANTOR:

 

EPIC REFERENCE LABS, INC.

 

 

By:/s/ Norma Villar

Name: Norma Villar

Title:Chief Financial Officer

 

	STATE OF ________________	)
	 	) SS.
	COUNTY OF ______________	)

 

The undersigned, a
Notary Public in and for the said County, in the State aforesaid, DO HEREBY CERTIFY that Norma Villar, the Chief Financial Officer
of EPIC Reference Labs, Inc., a Florida corporation, who is personally known to me to be the same person whose name is subscribed
to the foregoing instrument, appeared before me this day in person and acknowledged that he/she signed and delivered the said instrument
as his/her own free and voluntary act and as the free and voluntary act of said corporation, for the uses and purposes therein
set forth.

 

GIVEN under my hand and notarial seal this
_____ day of ________________, 20____.

 

	 	 
	 	Notary Public
	 	 
	 	My Commission Expires:
	 	 
	 	 

 

 

 

 

    	 	25	 

     

    

 

CONSENT AND AGREEMENT

 

The undersigned is a Guarantor, as that
term is defined in that certain securities purchase agreement by and between the Company and the Holder and, as such, the undersigned
hereby consents and agrees to the payment of the amounts contemplated in the senior secured, convertible, redeemable debenture,
documents contemplated thereby and to the provisions contained therein relating to conditions to be fulfilled and obligations to
be performed by the Company pursuant to or in connection with said senior secured, convertible, redeemable debenture to the same
extent as if the undersigned were a party to said senior secured, convertible, redeemable debenture.

 

GUARANTOR:

 

 

CLINLAB, INC.

 

By:/s/ Seamus Lagan

Name: Seamus Lagan

Title:President

 

	STATE OF ________________	)
	 	) SS.
	COUNTY OF ______________	)

 

The undersigned, a
Notary Public in and for the said County, in the State aforesaid, DO HEREBY CERTIFY that Seamus Lagan, the President of Clinlab,
Inc., a Florida corporation, who is personally known to me to be the same person whose name is subscribed to the foregoing instrument,
appeared before me this day in person and acknowledged that he/she signed and delivered the said instrument as his/her own free
and voluntary act and as the free and voluntary act of said corporation, for the uses and purposes therein set forth.

 

GIVEN under my hand and notarial seal this
_____ day of ________________, 20____.

 

	 	 
	 	Notary Public
	 	 
	 	My Commission Expires:
	 	 
	 	 

 

 

 

    	 	26	 

     

    

 

CONSENT AND AGREEMENT

 

The undersigned is a Guarantor, as that
term is defined in that certain securities purchase agreement by and between the Company and the Holder and, as such, the undersigned
hereby consents and agrees to the payment of the amounts contemplated in the senior secured, convertible, redeemable debenture,
documents contemplated thereby and to the provisions contained therein relating to conditions to be fulfilled and obligations to
be performed by the Company pursuant to or in connection with said senior secured, convertible, redeemable debenture to the same
extent as if the undersigned were a party to said senior secured, convertible, redeemable debenture.

 

GUARANTOR:

 

MEDICAL MIME, INC.

 

 

By:/s/ Seamus Lagan

Name: Seamus Lagan

Title:Secretary

 

	STATE OF ________________	)
	 	) SS.
	COUNTY OF ______________	)

 

 

The undersigned, a
Notary Public in and for the said County, in the State aforesaid, DO HEREBY CERTIFY that Seamus Lagan, the Secretary of Medical
Mime, Inc., a Florida corporation, who is personally known to me to be the same person whose name is subscribed to the foregoing
instrument, appeared before me this day in person and acknowledged that he/she signed and delivered the said instrument as his/her
own free and voluntary act and as the free and voluntary act of said corporation, for the uses and purposes therein set forth.

 

GIVEN under my hand and notarial seal this
_____ day of ________________, 20____.

 

	 	 
	 	Notary Public
	 	 
	 	My Commission Expires:
	 	 
	 	 

 

 

    	 	27	 

     

    

 

 

CONSENT AND AGREEMENT

 

The undersigned is a Guarantor, as that
term is defined in that certain securities purchase agreement by and between the Company and the Holder and, as such, the undersigned
hereby consents and agrees to the payment of the amounts contemplated in the senior secured, convertible, redeemable debenture,
documents contemplated thereby and to the provisions contained therein relating to conditions to be fulfilled and obligations to
be performed by the Company pursuant to or in connection with said senior secured, convertible, redeemable debenture to the same
extent as if the undersigned were a party to said senior secured, convertible, redeemable debenture.

 

GUARANTOR:

 

EPINEX DIAGNOSTICS LABORATORIES, INC.

 

 

By:/s/ Norma Villar

Name: Norma Villar

Title:Chief Financial Officer

 

	STATE OF ________________	)
	 	) SS.
	COUNTY OF ______________	)

 

The undersigned, a
Notary Public in and for the said County, in the State aforesaid, DO HEREBY CERTIFY that Norma Villar, the Chief Financial Officer
of Epinex Diagnostics Laboratories, Inc., a California corporation, who is personally known to me to be the same person whose name
is subscribed to the foregoing instrument, appeared before me this day in person and acknowledged that he/she signed and delivered
the said instrument as his/her own free and voluntary act and as the free and voluntary act of said corporation, for the uses and
purposes therein set forth.

 

 

GIVEN under my hand and notarial seal this
_____ day of ________________, 20____.

 

	 	 
	 	Notary Public
	 	 
	 	My Commission Expires:
	 	 
	 	 

 

 

 

    	 	28	 

     

    

 

CONSENT AND AGREEMENT

 

The undersigned is a Guarantor, as that
term is defined in that certain securities purchase agreement by and between the Company and the Holder and, as such, the undersigned
hereby consents and agrees to the payment of the amounts contemplated in the senior secured, convertible, redeemable debenture,
documents contemplated thereby and to the provisions contained therein relating to conditions to be fulfilled and obligations to
be performed by the Company pursuant to or in connection with said senior secured, convertible, redeemable debenture to the same
extent as if the undersigned were a party to said senior secured, convertible, redeemable debenture.

 

GUARANTOR:

 

EPINEX DIAGNOSTICS LABORATORIES, INC.

 

 

By:/s/ Norma Villar

Name: Norma Villar

Title:Chief Financial Officer

 

	STATE OF ________________	)
	 	) SS.
	COUNTY OF ______________	)

 

The undersigned, a
Notary Public in and for the said County, in the State aforesaid, DO HEREBY CERTIFY that Norma Villar, the Chief Financial Officer
of Epinex Diagnostics Laboratories, Inc., a Nevada corporation, who is personally known to me to be the same person whose name
is subscribed to the foregoing instrument, appeared before me this day in person and acknowledged that he/she signed and delivered
the said instrument as his/her own free and voluntary act and as the free and voluntary act of said corporation, for the uses and
purposes therein set forth.

 

GIVEN under my hand and notarial seal this
_____ day of ________________, 20____.

 

	 	 
	 	Notary Public
	 	 
	 	My Commission Expires:
	 	 
	 	 

 

 

 

    	 	29	 

     

    

 

CONSENT AND AGREEMENT

 

The undersigned is a Guarantor, as that
term is defined in that certain securities purchase agreement by and between the Company and the Holder and, as such, the undersigned
hereby consents and agrees to the payment of the amounts contemplated in the senior secured, convertible, redeemable debenture,
documents contemplated thereby and to the provisions contained therein relating to conditions to be fulfilled and obligations to
be performed by the Company pursuant to or in connection with said senior secured, convertible, redeemable debenture to the same
extent as if the undersigned were a party to said senior secured, convertible, redeemable debenture.

 

GUARANTOR:

 

PLATINUM FINANCIAL SOLUTIONS, LLC

 

 

By:/s/ Pavlos Papageorgiou

Name: Pavlos Papageorgiou

Title:Manager

 

	STATE OF ________________	)
	 	) SS.
	COUNTY OF ______________	)

 

 

The undersigned, a
Notary Public in and for the said County, in the State aforesaid, DO HEREBY CERTIFY that Pavlos Papageorgiou, the Manager of Platinum
Financial Solutions, LLC., a Florida limited liability company, who is personally known to me to be the same person whose name
is subscribed to the foregoing instrument, appeared before me this day in person and acknowledged that he/she signed and delivered
the said instrument as his/her own free and voluntary act and as the free and voluntary act of said corporation, for the uses and
purposes therein set forth.

 

GIVEN under my hand and notarial seal this
_____ day of ________________, 20____.

 

	 	 
	 	Notary Public
	 	 
	 	My Commission Expires:
	 	 
	 	 

 

 

 

 

 

    	 	30	 

     

    

 

SCHEDULE A

 

PAYMENT SCHEDULE

 

	 	Period	 	
        Principal

        Balance
	Interest Payment	Principal Payment	Total Interest	Total payment	IB Fee	Payment Due
	9/11/2015	 	 	 	 	 	 	 	 	(3,000,000.00)
	10/11/2015	1	 	                        -   	         40,000.00 	                    -   	        40,000.00 	          40,000.00 	                       -   	40,000.00
	11/11/2015	2	 	                        -   	         40,000.00 	                    -   	        80,000.00 	          80,000.00 	                       -   	40,000.00
	12/11/2015	3	 	                        -   	         40,000.00 	                    -   	      120,000.00 	        120,000.00 	                       -   	40,000.00
	1/11/2016	4	 	                        -   	         40,000.00 	                    -   	      160,000.00 	        160,000.00 	                       -   	40,000.00
	2/11/2016	5	 	                        -   	         40,000.00 	                    -   	      200,000.00 	        200,000.00 	                       -   	40,000.00
	3/11/2016	6	 	                        -   	         40,000.00 	                    -   	      240,000.00 	        240,000.00 	                       -   	40,000.00
	4/11/2016	7	 	                        -   	         40,000.00 	                    -   	      280,000.00 	        280,000.00 	                       -   	40,000.00
	5/11/2016	8	 	                        -   	         40,000.00 	                    -   	      320,000.00 	        320,000.00 	                       -   	40,000.00
	6/11/2016	9	 	                        -   	         40,000.00 	                    -   	      360,000.00 	        360,000.00 	     100,000.00 	140,000.00
	7/11/2016	10	 	                        -   	         40,000.00 	                    -   	      400,000.00 	        400,000.00 	                       -   	40,000.00
	8/11/2016	11	 	                        -   	         40,000.00 	                    -   	      440,000.00 	        440,000.00 	                       -   	40,000.00
	9/11/2016	12	 	                        -   	         40,000.00 	                    -   	      480,000.00 	        480,000.00 	     100,000.00 	140,000.00
	10/11/2016	13	1	   3,000,000.00 	         40,000.00 	   232,192.57 	      520,000.00 	        752,192.57 	                       -   	272,192.57
	11/11/2016	14	2	   2,767,807.43 	         36,904.10 	   235,288.47 	      556,904.10 	    1,024,385.15 	                       -   	272,192.57
	12/11/2016	15	3	   2,532,518.95 	         33,766.92 	   238,425.65 	      590,671.02 	    1,296,577.72 	                       -   	272,192.57
	1/11/2017	16	4	   2,294,093.30 	         30,587.91 	   241,604.66 	      621,258.93 	    1,568,770.29 	     100,000.00 	372,192.57
	2/11/2017	17	5	   2,052,488.63 	         27,366.52 	   244,826.06 	      648,625.44 	    1,840,962.87 	                       -   	272,192.57
	3/11/2017	18	6	   1,807,662.58 	         24,102.17 	   248,090.41 	      672,727.61 	    2,113,155.44 	                       -   	272,192.57
	4/11/2017	19	7	   1,559,572.17 	         20,794.30 	   251,398.28 	      693,521.91 	    2,385,348.02 	                       -   	272,192.57
	5/11/2017	20	8	   1,308,173.89 	         17,442.32 	   254,750.26 	      710,964.23 	    2,657,540.59 	                       -   	272,192.57
	6/11/2017	21	9	   1,053,423.64 	         14,045.65 	   258,146.93 	      725,009.87 	    2,929,733.16 	                       -   	272,192.57
	7/11/2017	22	10	       795,276.71 	         10,603.69 	   261,588.88 	      735,613.56 	    3,201,925.74 	                       -   	272,192.57
	8/11/2017	23	11	       533,687.83 	           7,115.84 	   265,076.74 	      742,729.40 	    3,474,118.31 	                       -   	272,192.57
	9/11/2017	24	12	       268,611.09 	           3,581.48 	   268,611.09 	      746,310.88 	    3,746,310.88 	                       -   	272,192.57

 

 

 

 

 

    	 	31	 

     

    

 

EXHIBIT B

 

NOTICE OF CONVERSION

 

The undersigned
hereby elects to convert principal and/or interest under the Senior Secured, Convertible, Redeemable Debenture (the “Debenture”)
issued by Medytox Solutions, Inc., a corporation incorporated under the laws of the State of Nevada (the “Company”),
into shares of common stock, par value $0.0001 per share (the “Common Shares”), of the Company in accordance
with the conditions of the Debenture, as of the date written below.

 

Based solely
on information provided by the Company to Holder, the undersigned represents and warrants to the Company that its ownership of
the Common Shares does not exceed the Beneficial Ownership Limitation as specified under the Note.

 

 

	Conversion Calculations	___________________________
	Effective Date of Conversion:	 
	Principal
Amount and/or Interest to be Converted:	 ___________________________
	Number of Common Shares to be Issued:	___________________________

 

[HOLDER]

 

	 	By:	 	 
		 	 	 
	 	Name:	 	 
	 	 	 	 
	 	Title:	 	 
	 	 	 	 
	 	Address:	 	 
	 	 	 	 
	 	 	 	 

 

 

 

    	 	32Exhibit 10.1

 

SECURITIES PURCHASE AGREEMENT

 

This SECURITIES
PURCHASE AGREEMENT (the “Agreement”) is dated as of May 31, 2015 and effective as of September 11, 2015 (the
“Effective Date”), by and between MEDYTOX SOLUTIONS, INC., a
corporation incorporated under the laws of the State of Nevada (the “Company”), and TCA GLOBAL CREDIT MASTER
FUND, LP, a limited partnership organized and existing under the laws of the Cayman Islands (the “Buyer”).

 

WHEREAS, Buyer
desires to purchase from Company, and the Company desires to sell and issue to Buyer, upon the terms and subject to the conditions
contained herein, up to Six Million and No/100 United States Dollars ($6,000,000) of senior secured convertible, redeemable debentures
(in the form attached hereto as Exhibit A, the “Debenture(s)”), of which Three Million and No/100 United
States Dollars ($3,000,000) shall be purchased on the date hereof (the “First Closing”) for the total purchase
price of Three Million and No/100 United States Dollars ($3,000,000) (the “Purchase Price”), and up to Three
Million and No/100 United States Dollars ($3,000,000) may be purchased in additional closings as set forth in Section 4.2
below (the “Additional Closings”) (each of the First Closing and the Additional Closings are sometimes hereinafter
individually referred to as a “Closing” and collectively as the “Closings”), all subject
to the terms and provisions hereinafter set forth;

 

WHEREAS, the
Company, Medytox Information Technology, Inc., a corporation incorporated under the laws of the State of Florida, Medytox Institute
of Laboratory Medicine, Inc., a corporation incorporated under the laws of the State of Florida, Medical Billing Choices Inc.,
a corporation incorporated under the laws of the State of North Carolina, Medytox Diagnostics, Inc., a corporation incorporated
under the laws of the State of Florida, Medytox Medical Marketing & Sales, Inc., a corporation incorporated under the laws
of the State of Florida, PB Laboratories, LLC, a limited liability company organized and existing under the laws of the State of
Florida, Biohealth Medical Laboratory Inc., a corporation incorporated under the laws of the State of Florida, Alethea Laboratories,
Inc., a corporation incorporated under the laws of the State of Texas, International Technologies, LLC, a limited liability company
organized and existing under the laws of the State of New Jersey, EPIC Reference Labs, Inc., a corporation incorporated under laws
of the State of Florida, Clinlab, Inc., a corporation incorporated under the laws of the State of Florida, Medical Mime, Inc.,
a corporation incorporated under the laws of the State of Florida, Epinex Diagnostics Laboratories, Inc., a corporation incorporated
under the laws of the State of California, Epinex Diagnostics Laboratories, Inc., a corporation incorporated under the laws of
the State of Nevada, and Platinum Financial Solutions, LLC, a limited liability company organized and existing under the laws of
the State of Florida (together, jointly and severally, the “Guarantors), have each agreed to secure all of the Company’s
Obligations to Buyer under the Debentures, this Agreement and all other Transaction Documents by granting to the Buyer an unconditional
and continuing security interest in all of the assets and properties of the Company and the Guarantor, whether now existing or
hereafter acquired, pursuant to those certain Security Agreements, each dated as of the date hereof (in the forms attached hereto
as Exhibit B, the “Security Agreements”);

    	1

     

    

 

WHEREAS, the
Guarantors will receive a substantial benefit from the Buyer’s purchase of the Debenture and, as such, have agreed to guarantee
all of the Obligations of the Buyer under the Debentures, this Agreement and all other Transactions Documents pursuant to those
certain Guarantee Agreements, each dated as of the date hereof (in the form attached hereto as Exhibit C, the “Guarantee
Agreements”); and

 

WHEREAS, as
security for the payment and performance of any and all of the Company’s Obligations to Buyer under the Debentures, this
Agreement and all other Transaction Agreements, the Company has agreed to execute those certain Pledge Agreements in favor of Buyer,
whereby the Company shall pledge to the Buyer all of its right, title and interest in and to, and provide a first priority lien
and security interest on, certain issued and outstanding shares of common stock of the Pledged Companies, each dated as of the
date hereof (in the form attached hereto as Exhibit D, the “Pledge Agreements”).

 

NOW, THEREFORE,
in consideration of the premises and the mutual covenants of the parties hereinafter expressed and other good and valuable consideration,
the receipt and sufficiency of which is hereby acknowledged, the parties hereto, each intending to be legally bound, agree as follows:

 

ARTICLE I

RECITALS, EXHIBITS, SCHEDULES

 

The foregoing
recitals are true and correct and, together with the Schedules and Exhibits referred to hereafter, are hereby incorporated into
this Agreement by this reference.

 

ARTICLE II

DEFINITIONS

 

For purposes
of this Agreement, except as otherwise expressly provided or otherwise defined elsewhere in this Agreement, or unless the context
otherwise requires, the capitalized terms in this Agreement shall have the meanings assigned to them in this Article as follows:

 

2.1“Affiliate”
means, with respect to a Person, any other Person directly or indirectly controlling, controlled by, or under common control with,
such Person at any time during the period for which the determination of affiliation is being made. For purposes of this definition,
the term “control,” “controlling” “controlled” and words of similar import, when used
in this context, means, with respect to any Person, the possession, directly or indirectly, of the power to direct, or cause the
direction of, management policies of such Person, whether through the ownership of voting securities, by contract or otherwise.

 

2.2“Assets”
means all of the properties and assets of the Person in question, as the context may so require, whether real, personal or mixed,
tangible or intangible, wherever located, whether now owned or hereafter acquired.

    	2

     

    

 

2.3“Business
Day” shall mean any day other than a Saturday, Sunday or a legal holiday on which federal banks are authorized or required
to be closed for the conduct of commercial banking business.

 

2.4“Claims”
means any Proceedings, Judgments, Obligations, threats, losses, damages, deficiencies, settlements, assessments, charges, costs
and expenses of any nature or kind.

 

2.5“Common
Stock” means the common stock of the Company, par value $0.0001 per share.

 

2.6“Compliance
Certificate” means that certain compliance certificate executed by an officer of the Company in the form attached hereto
as Exhibit E.

 

2.7“Consent”
means any consent, approval, order or authorization of, or any declaration, filing or registration with, or any application or
report to, or any waiver by, or any other action (whether similar or dissimilar to any of the foregoing) of, by or with, any Person,
which is necessary in order to take a specified action or actions, in a specified manner and/or to achieve a specific result.

 

2.8“Contract”
means any written or oral contract, agreement, order or commitment of any nature whatsoever, including, any sales order, purchase
order, lease, sublease, license agreement, services agreement, loan agreement, mortgage, security agreement, guarantee, management
contract, employment agreement, consulting agreement, partnership agreement, shareholders agreement, buy-sell agreement, option,
warrant, debenture, subscription, call or put.

 

2.9“Collateral”
shall have the meaning given to it in the Security Agreements.

 

2.10“Debenture(s)”
shall have the meaning given to it in the preamble hereof.

 

2.11“Effective
Date” means the date so defined in the introductory paragraph of this Agreement.

 

2.12“Encumbrance”
means any lien, security interest, pledge, mortgage, easement, leasehold, assessment, tax, covenant, restriction, reservation,
conditional sale, prior assignment, or any other encumbrance, claim, burden or charge of any nature whatsoever.

 

2.13“Environmental
Requirements” means all Laws and requirements relating to human, health, safety or protection of the environment or to
emissions, discharges, releases or threatened releases of pollutants, contaminants, or Hazardous Materials in the environment (including,
without limitation, ambient air, surface water, ground water, land surface or subsurface strata), or otherwise relating to the
treatment, storage, disposal, transport or handling of any Hazardous Materials.

 

2.14“GAAP”
means generally accepted accounting principles, methods and practices set forth in the opinions and pronouncements of the Accounting
Principles Board and the American Institute of Certified Public Accountants, and statements and pronouncements of the Financial
Accounting Standards Board, or of such other Person as may be approved by a significant segment of the U.S. accounting profession,
in each case as of the date or period at issue, and as applied in the U.S. to U.S. companies.

 

    	3

     

    

 

2.15“Governmental
Authority” means any foreign, federal, state or local government, or any political subdivision thereof, or any court,
agency or other body, organization, group, stock market or exchange exercising any executive, legislative, judicial, quasi-judicial,
regulatory or administrative function of government.

 

2.16“Guarantee
Agreements” shall have the meaning given to it in the recitals hereof.

 

2.17“Guarantors”
shall have the meaning given to it in the recitals hereof.

 

2.18“Hazardous
Materials” means: (i) any chemicals, materials, substances or wastes which are now or hereafter become defined as or
included in the definition of “hazardous substances,” “hazardous wastes,” “hazardous materials,”
“extremely hazardous wastes,” “restricted hazardous wastes,” “toxic substances,” “toxic
pollutants” or words of similar import, under any Law; and (iii) any other chemical, material, substance, or waste, exposure
to which is now or hereafter prohibited, limited or regulated by any Governmental Authority.

 

2.19“Irrevocable
Transfer Agent Instructions” shall mean the Irrevocable Transfer Agent Instructions to be entered into by and among the
Buyer, the Company and the Company’s transfer agent, in the form attached hereto as Exhibit F.

 

2.20“Judgment”
means any order, writ, injunction, fine, citation, award, decree, or any other judgment of any nature whatsoever of any Governmental
Authority.

 

2.21“Law”
means any provision of any law, statute, ordinance, code, constitution, charter, treaty, rule or regulation of any Governmental
Authority.

 

 2.22 “Leases” means all leases for real or personal property.

 

2.23“Material
Adverse Effect” shall mean: (i) a material adverse change in, or a material adverse effect upon, the Assets, business,
properties, financial condition or results of operations of the Company; (ii) a material impairment of the ability of the Company
to perform any of its Obligations under any of the Transaction Documents; or (iii) a material adverse effect on: (A) any material
portion of the “Collateral” (as such term is defined in the Security Agreements); (B) the legality, validity, binding
effect or enforceability against the Company and the Guarantors of any of the Transaction Documents; (C) the perfection or priority
of any Encumbrance granted to Buyer under any Transaction Documents; (D) the rights or remedies of the Buyer under any of the Transaction
Documents; or (E) a material adverse effect or impairment on the Buyer’s ability to sell the shares of the Company’s
Common Stock issuable to Buyer under any Transaction Documents without limitation or restriction, except as specified therein.
For purposes of determining whether any of the foregoing changes, effects, impairments, or other events have occurred, such determination
shall be made by Buyer, in its sole, but reasonably exercised, discretion.

 

    	4

     

    

 

2.24“Material
Contract” shall mean any Contract to which the Company is a party or by which the Company or any of its Assets
are bound and which: (i) must be disclosed to any Governmental Authority pursuant to the laws, rules or regulations of any Governmental
Authority; (ii) involves aggregate payments of One Million Dollars ($1,000,000) or more to or from the Company; (iii) involves
delivery, purchase, licensing or provision, by or to the Company, of any goods, services, assets or other items having a value
(or potential value) over the term of such Contract of One Million Dollars ($1,000,000) or more or is otherwise material to the
conduct of the Company’s business as now conducted and as contemplated to be conducted in the future; (iii) involves a Company
Lease in the amount of One Million Dollars ($1,000,000) or more; (iv) imposes any guaranty, surety or indemnification obligations
on the Company in the amount of One Million Dollars ($1,000,000) or more; or (v) prohibits the Company from engaging in any business
or competing anywhere in the world.

 

2.25“Merger”
shall mean that transactions contemplated by that certain Agreement and Plan of Merger, dated as of April 15, 2015, by and among
CollabRx, Inc., CollabRx Merger Sub, Inc. and the Company, pursuant to which the Company will become a wholly-owned subsidiary
of CollabRx, Inc.

 

2.26“Obligation”
means, now existing or in the future, any debt, liability or obligation of any nature whatsoever (including any required performance
of any covenants or agreements), whether secured, unsecured, recourse, nonrecourse, liquidated, unliquidated, accrued, voluntary
or involuntary, direct or indirect, absolute, fixed, contingent, ascertained, unascertained, known, unknown, whether or not jointly
owed with others, whether or not from time to time decreased or extinguished and later decreased, created or incurred, or obligations
existing or incurred under this Agreement, the Debentures or any other Transaction Documents, or any other agreement between the
Company, the Guarantors and the Buyer, as such obligations may be amended, supplemented, converted, extended or modified from time
to time.

 

2.27“Ordinary
Course of Business” means the ordinary course of business of the Person in question, consistent with past custom
and practice (including with respect to quantity, quality and frequency).

 

2.28“OTC
Markets” means the OTC Markets Group, Inc.

 

2.29“Permit”
means any license, permit, approval, waiver, order, authorization, right or privilege of any nature whatsoever, granted, issued,
approved or allowed by any Governmental Authority.

 

2.30“Person”
means any individual, sole proprietorship, joint venture, partnership, company, corporation, association, cooperation, trust,
estate, Governmental Authority, or any other entity of any nature whatsoever.

 

    	5

     

    

 

2.31“Pledge
Agreement” shall have the meaning given to it in the recitals hereof.

 

2.32“Pledged
Companies” shall mean Medytox Medical Marketing & Sales, Inc., Medical Billing Choices Inc., Medytox Diagnostics,
Inc., Medytox Information & Technology, Inc. and Platinum Financial Solutions Ltd.

 

2.33“Principal
Trading Market” shall mean the Nasdaq Global Select Market, the Nasdaq Global Market, the Nasdaq Capital Market, the
OTC Bulletin Board, the OTC Markets, the so-called OTC Pink Sheets, the NYSE Euronext or the New York Stock Exchange, whichever
is at the time the principal trading exchange or market for the Common Stock.

 

2.34“Proceeding”
means any demand, claim, suit, action, litigation, investigation, audit, study, arbitration, administrative hearing, or any
other proceeding of any nature whatsoever.

 

2.35“Real
Property” means any real estate, land, building, structure, improvement, fixture or other real property of any
nature whatsoever, including, but not limited to, fee and leasehold interests.

 

2.36“Rule
144” shall mean Rule 144 or Rule 144A promulgated under the Securities Act (or a successor rule thereto.

 

2.37“SEC”
shall mean the United States Securities and Exchange Commission.

 

2.38“Securities”
means, collectively, the Debentures and any additional shares of Common Stock issuable in connection with a conversion of the
Debentures, or the terms of this Agreement or any other Transaction Documents.

 

2.39“Security
Agreements” shall have the meaning given to it in the recitals hereof.

 

2.40“Tax”
means (i) any foreign, federal, state or local income, profits, gross receipts, franchise, sales, use, occupancy, general property,
real property, personal property, intangible property, transfer, fuel, excise, accumulated earnings, personal holding company,
unemployment compensation, social security, withholding taxes, payroll taxes, or any other tax of any nature whatsoever, (ii) any
foreign, federal, state or local governmental fee, qualification fee, annual report fee, filing fee, occupation fee, assessment,
or any other fee or assessment of any nature whatsoever, or (iii) any deficiency, interest or penalty imposed with respect to any
of the foregoing.

 

2.41“Tax
Return” means any tax return, filing, declaration, information statement or other form or document required to be filed
in connection with or with respect to any Tax.

 

2.42“Transaction
Documents” means this Agreement any and all documents or instruments executed or to be executed by the Company and/or
the Guarantors in connection with this Agreement, including the Debentures, the Security Agreements, the Guarantee Agreements,
the Use of Proceeds Confirmation, the Control Agreement, the Irrevocable Transfer Agent Instructions, and the Pledge Agreements,
together with all modifications, amendments, extensions, future advances, renewals, and substitutions thereof.

 

    	6

     

    

 

2.43“Use
of Proceeds Confirmation” means that certain use of proceeds confirmation executed by an officer of the Company in the
form attached hereto as Exhibit G.

 

ARTICLE III

INTERPRETATION

 

In this Agreement,
unless the express context otherwise requires: (i) the words “herein,” “hereof” and “hereunder”
and words of similar import refer to this Agreement as a whole and not to any particular provision of this Agreement; (ii) references
to the words “Article” or “Section” refer to the respective Articles and Sections of this Agreement, and
references to “Exhibit” or “Schedule” refer to the respective Exhibits and Schedules annexed hereto; (iii)
references to a “party” mean a party to this Agreement and include references to such party’s permitted successors
and permitted assigns; (iv) references to a “third party” mean a Person not a party to this Agreement; (v) references
to the words “share” or “shareholder”, if in reference to the Company, shall refer to “units”
or “unitholder” respectively and (v) the terms “dollars” and “$” means U.S. dollars; (vi) wherever
the word “include,” “includes” or “including” is used in this Agreement, it will be deemed
to be followed by the words “without limitation”.

 

ARTICLE IV

PURCHASE AND SALE OF DEBENTURES

 

4.1Purchase
and Sale of Debentures. Subject to the satisfaction (or waiver) of the terms and conditions of this Agreement, Buyer agrees
to purchase, at each Closing, and Company agrees to sell and issue to Buyer, at each Closing, Debentures in the amount of the Purchase
Price applicable to each Closing as more specifically set forth below.

 

4.2Closing
Dates. The First Closing of the purchase and sale of the Debentures shall be for Three Million and No/100 United States Dollars
($3,000,000), and shall take place on the Effective Date, subject to satisfaction of the conditions to the First Closing set forth
in this Agreement (the “First Closing Date”). Additional Closings of the purchase and sale of the Debentures
shall be at such times and for such amounts as determined in accordance with Section 4.4 below, subject to satisfaction
of the conditions to the Additional Closings set forth in this Agreement (the “Additional Closing Dates”) (collectively
referred to as the “Closing Dates”). The Closings shall occur on the respective Closing Dates through the use
of overnight mails and subject to customary escrow instructions from Buyer and its counsel, or in such other manner as is mutually
agreed to by the Company and the Buyer.

 

4.3Form
of Payment. Subject to the satisfaction of the terms and conditions of this Agreement, on each Closing Date: (i) the Buyer
shall deliver to the Company, to a Company account designated by the Company, the aggregate proceeds for the Debentures to be issued
and sold to Buyer at each such Closing, minus the fees to be paid directly from the proceeds of each such Closing as set forth
in this Agreement, in the form of wire transfers of immediately available U.S. dollars; and (ii) the Company shall deliver to Buyer
the Securities which Buyer is purchasing hereunder at each Closing, duly executed on behalf of the Company, together with any other
documents required to be delivered pursuant to this Agreement.

 

    	7

     

    

 

4.4Additional
Closings. At any time after the First Closing but prior to the maturity date of any of the Debentures issued in the First Closing,
the Company may request that Buyer purchase additional Debentures hereunder in Additional Closings by written notice to Buyer,
and, subject to the conditions below, Buyer shall purchase such additional Debentures in such amounts and at such times as Buyer
and the Company may mutually agree, so long as the following conditions have been satisfied, in Buyer’s sole and absolute
discretion: (i) no default or “Event of Default” (as such term is defined in any of the Transaction Documents) shall
have occurred and be continuing under this Agreement or any other Transaction Documents, and no event shall have occurred and be
continuing that, with the passage of time, the giving of notice, or both, would constitute a default or an Event of Default hereunder
or thereunder; and (ii) any additional purchase of Debentures beyond the purchase of Debentures at the First Closing shall have
been approved by Buyer, which approval may be given or withheld in Buyer’s sole and absolute discretion.

 

ARTICLE V

BUYER’S REPRESENTATIONS
AND WARRANTIES

 

Buyer represents and warrants to the
Company, that:

 

5.1Investment
Purpose. Buyer is acquiring the Securities for its own account for investment only and not with a view towards, or for resale
in connection with, the public sale or distribution thereof.

 

5.2Accredited
Buyer Status. Buyer is an “accredited investor” as that term is defined in Rule 501 of Regulation D, as promulgated
under the Securities Act of 1933.

 

5.3Reliance
on Exemptions. Buyer understands that the Securities are being offered and sold to it in reliance on specific exemptions from
the registration requirements of United States federal and state securities laws and that the Company is relying in part upon the
truth and accuracy of, and Buyer’s compliance with, the representations, warranties, agreements, acknowledgments and understandings
of Buyer set forth herein in order to determine the availability of such exemptions and the eligibility of Buyer to acquire the
Securities.

 

    	8

     

    

 

5.4Information.
Buyer and its advisors, if any, have been furnished with all materials they have requested relating to the business, finances and
operations of the Company and information Buyer deemed material to making an informed investment decision regarding its purchase
of the Securities. Buyer and its advisors, if any, have been afforded the opportunity to ask questions of the Company and its management.
Neither such inquiries, nor any materials provided to Buyer, nor any other due diligence investigations conducted by Buyer or its
advisors, if any, or its representatives, shall modify, amend or affect Buyer’s right to fully rely on the Company’s
representations and warranties contained in Article VI below. Buyer understands that its investment in the Securities involves
a high degree of risk. Buyer is in a position regarding the Company, which, based upon economic bargaining power, enabled and enables
Buyer to obtain information from the Company in order to evaluate the merits and risks of this investment. Buyer has sought such
accounting, legal and tax advice as it has considered necessary to make an informed investment decision with respect to its acquisition
of the Securities.

 

5.5No
Governmental Review. Buyer understands that no United States federal or state Governmental Authority has passed on or made
any recommendation or endorsement of the Securities, or the fairness or suitability of the investment in the Securities, nor have
such Governmental Authorities passed upon or endorsed the merits of the offering of the Securities.

 

5.6Authorization,
Enforcement. This Agreement has been duly and validly authorized, executed and delivered on behalf of Buyer and is a valid
and binding agreement of Buyer, enforceable in accordance with its terms, except as such enforceability may be limited by general
principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation and other similar laws relating
to, or affecting generally, the enforcement of applicable creditors’ rights and remedies.

 

ARTICLE VI

REPRESENTATIONS AND WARRANTIES
OF THE COMPANY

 

To induce
the Buyer to purchase the Securities, the Company makes the following representations and warranties to Buyer, each of which shall
be true and correct in all respects as of the date of the execution and delivery of this Agreement, and which shall survive the
execution and delivery of this Agreement:

 

6.1Subsidiaries.
A list of all of the Company’s Subsidiaries, direct and indirect, is set forth in Schedule 6.1 hereto. 

 

6.2Organization.
The Company is a corporation, duly incorporated, validly existing and in good standing under the Laws of the jurisdiction in which
it is incorporated. The Company has the full power and authority and all necessary certificates, licenses, approvals and Permits
to: (i) enter into and execute this Agreement and the Transaction Documents and to perform all of its Obligations hereunder and
thereunder; and (ii) own and operate its Assets and properties and to conduct and carry on its business as and to the extent now
conducted. The Company is duly qualified to transact business and is in good standing as a foreign corporation in each jurisdiction
where the character of its business or the ownership or use and operation of its Assets or properties requires such qualification.
The exact legal name of the Company is as set forth in the preamble to this Agreement, and the Company does not currently conduct,
nor has the Company, during the last five (5) years conducted, business under any other name or trade name.

 

    	9

     

    

 

6.3Authority
and Approval of Agreement; Binding Effect. The execution and delivery by Company of this Agreement and the Transaction Documents,
and the performance by Company of all of its Obligations hereunder and thereunder, including the issuance of the Securities, have
been duly and validly authorized and approved by the Company and its board of managers pursuant to all applicable Laws and no other
action or Consent on the part of Company, its board of managers, members or any other Person is necessary or required by the Company
to execute this Agreement and the Transaction Documents, consummate the transactions contemplated herein and therein, perform all
of Company’s Obligations hereunder and thereunder, or to issue the Securities. This Agreement and each of the Transaction
Documents have been duly and validly executed by Company (and the officer executing this Agreement and all such other Transaction
Documents is duly authorized to act and execute same on behalf of Company) and constitute the valid and legally binding agreements
of Company, enforceable against Company in accordance with their respective terms, except as such enforceability may be limited
by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation and other similar
laws relating to, or affecting generally, the enforcement of applicable creditors’ rights and remedies.

 

6.4Capitalization.
The authorized capital stock of the Company consists of five hundred million (500,000,000) shares of Common Stock and one hundred
million (100,000,000) shares of preferred stock, par value $0.0001 per share (the “Preferred Stock”), of
which thirty million nine hundred thirty-one thousand twenty six (30,931,026) shares of Common Stock are issued and outstanding
as of the date hereof, and one hundred thousand (100,000,000) shares of Preferred Stock are issued and outstanding as of the date
hereof. All of such outstanding shares have been validly issued and are fully paid and nonassessable, have been issued in compliance
with all foreign, federal and state securities laws and none of such outstanding shares were issued in violation of any preemptive
rights or similar rights to subscribe for or purchase securities. As of the Effective Date, no shares of the Company’s capital
stock are subject to preemptive rights or any other similar rights or any Claims or Encumbrances suffered or permitted by the Company.
The Common Stock is currently quoted on the OTC Markets under the trading symbol “MMMS”. The Company has received no
notice, either oral or written, with respect to the continued eligibility of the Common Stock for quotation on the Principal Trading
Market, and the Company has maintained all requirements on its part for the continuation of such quotation. Except as disclosed
in the “Public Documents” (as hereinafter defined) and except for the Securities to be issued pursuant to this Agreement,
as of the date hereof: (i) there are no outstanding options, warrants, scrip, rights to subscribe to, calls or commitments of any
character whatsoever relating to, or securities or rights convertible into, any shares of capital stock of the Company or any of
its Subsidiaries, or Contracts, commitments, understandings or arrangements by which the Company or any of its Subsidiaries is
or may become bound to issue additional shares of capital stock of the Company or any of its Subsidiaries, or options, warrants,
scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible
into, any shares of capital stock of the Company or any of its Subsidiaries; (ii) there are no outstanding debt securities, notes,
credit agreements, credit facilities or other Contracts or instruments evidencing indebtedness of the Company or any of its Subsidiaries,
or by which the Company or any of its Subsidiaries is or may become bound; (iii) there are no outstanding registration statements
with respect to the Company or any of its securities; (iv) there are no agreements or arrangements under which the Company or any
of its Subsidiaries is obligated to register the sale of any of their securities under the Securities Act (except pursuant to this
Agreement); (v) there are no financing statements securing obligations filed in connection with the Company or any of its Assets;
(vi) there are no securities or instruments containing anti-dilution or similar provisions that will be triggered by this Agreement
or any related agreement or the consummation of the transactions described herein or therein; and (vii) there are no outstanding
securities or instruments of the Company which contain any redemption or similar provisions, and there are no Contracts by which
the Company is or may become bound to redeem a security of the Company. The Company has furnished to the Buyer true, complete and
correct copies of: (I) the Company’s Articles of Incorporation, as amended and as in effect on the date hereof; and (II)
the Company’s Bylaws, as in effect on the date hereof (together, the “Organizational Documents”).
Except for the Organizational Documents or as disclosed in the Public Documents, there are no other shareholder agreements, voting
agreements or other Contracts of any nature or kind that restrict, limit or in any manner impose Obligations on the governance
of the Company.

 

    	10

     

    

 

6.5No
Conflicts; Consents and Approvals. The execution, delivery and performance of this Agreement and the Transaction Documents,
and the consummation of the transactions contemplated hereby and thereby, including the issuance of any of the Securities, will
not: (i) constitute a violation of or conflict with the Organizational Documents of the Company; (ii) constitute a violation of,
or a default or breach under (either immediately, upon notice, upon lapse of time, or both), or conflicts with, or gives to any
other Person any rights of termination, amendment, acceleration or cancellation of, any provision of any Contract to which Company
is a party or by which any of its Assets or properties may be bound; (iii) constitute a violation of, or a default or breach under
(either immediately, upon notice, upon lapse of time, or both), or conflicts with, any Judgment; (iv) constitute a violation of,
or conflict with, any Law (including United States federal and state securities Laws); or (v) result in the loss or adverse modification
of, or the imposition of any fine, penalty or other Encumbrance with respect to, any Permit granted or issued to, or otherwise
held by or for the use of, Company or any of Company’s Assets. The Company is not in violation of its Organizational Documents
and the Company is not in default or breach (and no event has occurred which with notice or lapse of time or both could put the
Company in default or breach) under, and the Company has not taken any action or failed to take any action that would give to any
other Person any rights of termination, amendment, acceleration or cancellation of, any Contract to which the Company is a party
or by which any property or Assets of the Company are bound or affected. The businesses of the Company are not being conducted,
and shall not be conducted so long as Buyer owns any of the Securities, in violation of any Law. Except as specifically contemplated
by this Agreement, the Company is not required to obtain any Consent of, from, or with any Governmental Authority, or any other
Person, in order for it to execute, deliver or perform any of its Obligations under this Agreement or the Transaction Documents
in accordance with the terms hereof or thereof, or to issue and sell the Securities in accordance with the terms hereof. All Consents
which the Company is required to obtain pursuant to the immediately preceding sentence have been obtained or effected on or prior
to the date hereof. The Company is not aware of any facts or circumstances which might give rise to any of the foregoing.

 

    	11

     

    

 

6.6Issuance
of Securities. The Securities are duly authorized and, upon issuance in accordance with the terms hereof, shall be duly issued,
fully paid and non-assessable, and free from all Encumbrances with respect to the issue thereof, and will be issued in compliance
with all applicable United States federal and state securities Laws. 

 

6.7Financial
Statements. The Company has delivered to the Buyer an audited consolidated Balance Sheet and Statement of Income for fiscal
year ending December 31, 2014, and an unaudited consolidated Balance Sheet and Statement of Income as of June 30, 2015 (collectively,
together with any financial statements filed by the Company with the SEC, any Principal Trading Market, or any other Governmental
Authority, if applicable, the “Financial Statements”). The Financial Statements have been prepared in accordance
with GAAP, consistently applied, during the periods involved (except: (i) as may be otherwise indicated in such Financial Statements
or the notes thereto; or (ii) in the case of unaudited interim statements, to the extent they may exclude footnotes or may be condensed
or summary statements), and fairly and accurately present in all material respects the consolidated financial position of the Company
and its Subsidiaries as of the dates thereof and the consolidated results of its operations and cash flows for the periods then
ended (subject, in the case of unaudited statements, to normal year-end audit adjustments). To the best knowledge of the Company,
no other information provided by or on behalf of the Company and its Subsidiaries to the Buyer, either as a disclosure schedule
to this Agreement, or otherwise in connection with Buyer’s due diligence investigation of the Company and its Subsidiaries,
contains any untrue statement of a material fact or omits to state any material fact necessary in order to make the statements
therein, in the light of the circumstance under which they are or were made, not misleading.

 

6.8Public
Documents. The Common Stock of the Company is registered pursuant to Section 12 of the Exchange Act and the Company is subject
to the reporting requirements of Section 13 or 15(d) of the Exchange Act. The Company has timely filed all reports, schedules,
forms, statements and other documents required to be filed by it with the SEC, the OTC Markets, or any other Governmental Authority,
as applicable (all of the foregoing filed within the two (2) years preceding the date hereof or amended after the date hereof and
all exhibits included therein and financial statements and schedules thereto and documents incorporated by reference therein, being
hereinafter referred to as the “Public Documents”). The Company is current with its filing obligations with
the SEC, the OTC Markets, or any other Governmental Authority, as applicable, and all Public Documents have been filed on a timely
basis by the Company. The Company represents and warrants that true and complete copies of the Public Documents are available on
the SEC website or the OTC Markets website, as applicable (www.sec.gov, or www.otcmarkets.com) at no charge to Buyer, and Buyer
acknowledges that it may retrieve all Public Documents from such websites and Buyer’s access to such Public Documents through
such website shall constitute delivery of the Public Documents to Buyer; provided, however, that if Buyer is unable to obtain any
of such Public Documents from such websites at no charge, as result of such websites not being available or any other reason beyond
Buyer’s control, then upon request from Buyer, the Company shall deliver to Buyer true and complete copies of such Public
Documents. The Company shall also deliver to Buyer true and complete copies of all draft filings, reports, schedules, statements
and other documents required to be filed with the requirements of the OTC Markets that have been prepared but not filed with the
OTC Markets as of the date hereof. None of the Public Documents, at the time they were filed with the SEC, the OTC Markets, or
other Governmental Authority, as applicable, contained any untrue statement of a material fact or omitted to state a material fact
required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they
were made, not misleading. None of the statements made in any such Public Documents is, or has been, required to be amended or
updated under applicable law (except for such statements as have been amended or updated in subsequent filings prior the date hereof,
which amendments or updates are also part of the Public Documents). As of their respective dates, the consolidated financial statements
of the Company and its Subsidiaries included in the Public Documents complied in all material respects with applicable accounting
requirements and any published rules and regulations of the SEC and OTC Markets with respect thereto. 

 

    	12

     

    

 

6.9Absence
of Certain Changes. Since the date of the most recent of the Financial Statements, none of the following have occurred:

 

(a)Except
as disclosed in Schedule 6.9, there has been no event or circumstance of any nature whatsoever that has resulted in, or
could reasonably be expected to result in, a Material Adverse Effect; or

 

(b)Any
transaction, event, action, development, payment, or any other matter of any nature whatsoever entered into by the Company other
than in the Company’s Ordinary Course of Business.

 

6.10Absence
of Litigation or Adverse Matters. Except as disclosed on Schedule 6.10, no condition, circumstance, event, agreement,
document, instrument, restriction, litigation or Proceeding (or threatened litigation or Proceeding or basis therefor) exists which:
(i) could adversely affect the validity or priority of the Encumbrances granted to the Buyer under the Transaction Documents; (ii)
could adversely affect the ability of the Company to perform its Obligations under the Transaction Documents; (iii) would constitute
a default under any of the Transaction Documents; (iv) would constitute such a default with the giving of notice or lapse of time
or both; or (v) would constitute or give rise to a Material Adverse Effect. In addition, except as disclosed on Schedule 6.10:
(vi) there is no Proceeding before or by any Governmental Authority or any other Person, pending, or the best of Company’s
knowledge, threatened or contemplated by, against or affecting the Company, its business or Assets; (vii) there is no outstanding
Judgments against or affecting the Company, its business or Assets; (viii) the Company is not in breach or violation of any Contract;
and (ix) the Company has not received any material complaint from any customer, supplier, vendor or employee.

 

    	13

     

    

 

6.11Liabilities
and Indebtedness of the Company. The Company does not have any Obligations of any nature whatsoever, except: (i) as disclosed
in the Financial Statements; or (iii) Obligations incurred in the Ordinary Course of Business since the date of the most recent
Financial Statements which do not or would not, individually or in the aggregate, exceed One Hundred Thousand Dollars ($100,000)
or otherwise have a Material Adverse Effect.

 

6.12Title
to Assets. The Company has good and marketable title to, or a valid leasehold interest in, all of its Assets which are
material to the business and operations of the Company as presently conducted, free and clear of all Encumbrances or
restrictions on the transfer or use of same, except for $1,282,557.27 owed to the Internal Revenue Service. Except as
would not have a Material Adverse Effect, the Company’s Assets are in good operating condition and repair, ordinary
wear and tear excepted, and are free of any latent or patent defects which might impair their usefulness, and are suitable
for the purposes for which they are currently used and for the purposes for which they are proposed to be used.

 

 6.13 Real Estate.

 

(a)Real
Property Ownership. Except for the Company Leases and as set forth on Schedule 6.13, the Company and the Guarantors
do not own any Real Property. 

 

(b)Real
Property Leases. Except for ordinary office Leases disclosed to the Buyer in writing prior to the date hereof (the “Company
Leases”), the Company does not lease any other Real Property. With respect to each of the Company Leases: (i) the
Company has been in peaceful possession of the property leased thereunder and neither the Company nor the landlord is in default
thereunder; (ii) no waiver, indulgence or postponement of any of the Obligations thereunder has been granted by the Company or
landlord thereunder; and (iii) there exists no event, occurrence, condition or act known to the Company which, upon notice or lapse
of time or both, would be or could become a default thereunder or which could result in the termination of the Company Leases,
or any of them, or have a Material Adverse Effect on the business of the Company, its Assets or its operations or financial results.
The Company has not violated nor breached any provision of any such Company Leases, and all Obligations required to be performed
by the Company under any of such Company Leases have been fully, timely and properly performed. The Company has delivered to the
Buyer true, correct and complete copies of all Company Leases, including all modifications and amendments thereto, whether in writing
or otherwise. The Company has not received any written or oral notice to the effect that any of the Company Leases will not be
renewed at the termination of the term of such Company Leases, or that any of such Company Leases will be renewed only at higher
rents.

 

6.14Material
Contracts. An accurate, current and complete copy of each of the Material Contracts has been furnished to Buyer, and each of
the Material Contracts constitutes the entire agreement of the respective parties thereto relating to the subject matter thereof.
There are no outstanding offers, bids, proposals or quotations made by Company which, if accepted, would create a Material Contract
with Company. Each of the Material Contracts is in full force and effect and is a valid and binding Obligation of the parties thereto
in accordance with the terms and conditions thereof. To the knowledge of the Company and its officers, all Obligations required
to be performed under the terms of each of the Material Contracts by any party thereto have been fully performed by all parties
thereto, and no party to any Material Contracts is in default with respect to any term or condition thereof, nor has any event
occurred which , through the passage of time or the giving of notice, or both, would constitute a default thereunder or would cause
the acceleration or modification of any Obligation of any party thereto or the creation of any Encumbrance upon any of the Assets
of the Company. Further, the Company has received no notice, nor does the Company have any knowledge, of any pending or contemplated
termination of any of the Material Contracts and, no such termination is proposed or has been threatened, whether in writing or
orally.

 

    	14

     

    

 

6.15Compliance
with Laws. To the knowledge of the Company and its officers, the Company is and at all times has been in substantial compliance
with all Laws. The Company has not received any notice that it is in violation of, has violated, or is under investigation with
respect to, or has been threatened to be charged with, any violation of any Law.

 

6.16Intellectual
Property. The Company owns or possesses adequate and legally enforceable rights or licenses to use all trademarks, trade names,
service marks, service mark registrations, service names, patents, patent rights, copyrights, inventions, licenses, approvals,
governmental authorizations, trade secrets and all other intellectual property rights necessary to conduct its business as now
conducted. The Company does not have any knowledge of any infringement by the Company of trademark, trade name rights, patents,
patent rights, copyrights, inventions, licenses, service names, service marks, service mark registrations, trade secret or other
intellectual property rights of others, and, to the knowledge of the Company, there is no Claim being made or brought against,
or to the Company’s knowledge, being threatened against, the Company regarding trademark, trade name, patents, patent rights,
invention, copyright, license, service names, service marks, service mark registrations, trade secret or other intellectual property
infringement; and the Company is unaware of any facts or circumstances which might give rise to any of the foregoing.

 

6.17Labor
and Employment Matters. The Company is not involved in any labor dispute or, to the knowledge of the Company, is any such dispute
threatened. To the knowledge of the Company and its officers, none of the Company’s employees is a member of a union and
the Company believes that its relations with its employees are good. To the knowledge of the Company and its officers, the Company
has complied in all material respects with all Laws relating to employment matters, civil rights and equal employment opportunities.

 

6.18Employee
Benefit Plans. Except as disclosed to the Buyer in writing prior to the date hereof, the Company does not have and has not
ever maintained, and has no Obligations with respect to any employee benefit plans or arrangements, including employee pension
benefit plans, as defined in Section 3(2) of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”),
multiemployer plans, as defined in Section 3(37) of ERISA, employee welfare benefit plans, as defined in Section 3(1) of ERISA,
deferred compensation plans, stock option plans, bonus plans, stock purchase plans, hospitalization, disability and other insurance
plans, severance or termination pay plans and policies, whether or not described in Section 3(3) of ERISA, in which employees,
their spouses or dependents of the Company participate (collectively, the “Employee Benefit Plans”). To
the Company’s knowledge, all Employee Benefit Plans meet the minimum funding standards of Section 302 of ERISA, where applicable,
and each such Employee Benefit Plan that is intended to be qualified within the meaning of Section 401 of the Internal Revenue
Code of 1986 is qualified. No withdrawal liability has been incurred under any such Employee Benefit Plans and no “Reportable
Event” or “Prohibited Transaction” (as such terms are defined in ERISA), has occurred with respect to any such
Employee Benefit Plans, unless approved by the appropriate Governmental Authority. To the Company’s knowledge, the Company
has promptly paid and discharged all Obligations arising under ERISA of a character which if unpaid or unperformed might result
in the imposition of an Encumbrance against any of its Assets or otherwise have a Material Adverse Effect.

 

    	15

     

    

 

6.19Tax
Matters. The Company and each Guarantor has made and timely filed all Tax Returns required by any jurisdiction to which it
is subject, and each such Tax Return has been prepared in compliance with all applicable Laws, and all such Tax Returns are true
and accurate in all respects. Except and only to the extent that the Company and each Guarantor has set aside on its books provisions
reasonably adequate for the payment of all unpaid and unreported Taxes, the Company has timely paid all Taxes shown or determined
to be due on such Tax Returns, except those being contested in good faith, and the Company has set aside on its books provision
reasonably adequate for the payment of all Taxes for periods subsequent to the periods to which such Tax Returns apply. Except
as disclosed in the Company’s Financial Statements and for $1,282,557.27 owed to the Internal Revenue Service, there are
no unpaid Taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company
know of no basis for any such claim. Except as disclosed in Schedule 6.19, the Company has withheld and paid all Taxes to
the appropriate Governmental Authority required to have been withheld and paid in connection with amounts paid or owing to any
Person. There is no Proceeding or Claim for refund now in progress, pending or threatened against or with respect to the Company
regarding Taxes.

 

6.20Insurance.
The Company is covered by valid, outstanding and enforceable policies of insurance which were issued to it by reputable insurers
of recognized financial responsibility, covering its properties, Assets and businesses against losses and risks normally insured
against by other corporations or entities in the same or similar lines of businesses as the Company is engaged and in coverage
amounts which are prudent and typically and reasonably carried by such other corporations or entities (the “Insurance
Policies”). Such Insurance Policies are in full force and effect, and all premiums due thereon have been paid.
None of the Insurance Policies will lapse or terminate as a result of the transactions contemplated by this Agreement. The Company
has complied with the provisions of such Insurance Policies. The Company has not been refused any insurance coverage sought or
applied for and the Company does not have any reason to believe that it will not be able to renew its existing Insurance Policies
as and when such Insurance Policies expire or to obtain similar coverage from similar insurers as may be necessary to continue
its business at a cost that would not materially and adversely affect the condition, financial or otherwise, or the earnings, business
or operations of the Company.

 

    	16

     

    

 

6.21Permits.
The Company possesses all Permits necessary to conduct its business, and the Company has not received any notice of, or is otherwise
involved in any Proceedings relating to, the revocation or modification of any such Permits. All such Permits are valid and in
full force and effect and the Company is in full compliance with the respective requirements of all such Permits.

 

6.22Bank
Accounts; Business Location. Schedule 6.22 sets forth, with respect to each account of the Company with any bank,
broker or other depository institution: (i) the name and account number of such account; (ii) the name and address of the institution
where such account is held; (iii) the name of any Person(s) holding a power of attorney with respect to such account, if any; and
(iv) the names of all authorized signatories and other Persons authorized to withdraw funds from each such account. The Company
has no office or place of business other than as identified on Schedule 6.22 and the Company’s principal places
of business and chief executive offices are indicated on Schedule 6.22. All books and records of the Company and
other material Assets of the Company are held or located at the principal offices of the Company indicated on Schedule 6.22.

 

6.23Environmental
Laws. Except as are used in such amounts as are customary in the Company’s Ordinary Course of Business and in compliance
with all applicable Environmental Laws, the Company represents and warrants to Buyer that: (i) the Company has not generated, used,
stored, treated, transported, manufactured, handled, produced or disposed of any Hazardous Materials, on or off any of the premises
of the Company (whether or not owned by the Company) in any manner which at any time violates any Environmental Law or any Permit,
certificate, approval or similar authorization thereunder; (ii) the operations of the Company comply in all material respects with
all Environmental Laws and all Permits certificates, approvals and similar authorizations thereunder; (iii) there has been no investigation,
Proceeding, complaint, order, directive, Claim, citation or notice by any Governmental Authority or any other Person, nor is any
pending or, to the Company’s knowledge, threatened; and (iv) the Company does not have any liability, contingent or otherwise,
in connection with a release, spill or discharge, threatened or actual, of any Hazardous Materials or the generation, use, storage,
treatment, transportation, manufacture, handling, production or disposal of any Hazardous Material.

 

6.24Illegal
Payments. Neither the Company, nor any director, officer, agent, employee or other Person acting on behalf of the Company has,
in the course of his actions for, or on behalf of, the Company: (i) used any corporate funds for any unlawful contribution, gift,
entertainment or other unlawful expenses relating to political activity; (ii) made any direct or indirect unlawful payment to any
foreign or domestic government official or employee from corporate funds; (iii) violated or is in violation of any provision of
the U.S. Foreign Corrupt Practices Act of 1977, as amended; or (iv) made any bribe, rebate, payoff, influence payment, kickback
or other unlawful payment to any foreign or domestic government official or employee.

 

    	17

     

    

 

6.25Related
Party Transactions. Except as disclosed in the Company’s financial statements and for arm’s length transactions
pursuant to which the Company makes payments in the Ordinary Course of Business upon terms no less favorable than the Company could
obtain from third parties, none of the officers, directors or employees of the Company, nor any stockholders who own, legally or
beneficially, five percent (5%) or more of the issued and outstanding shares of any class of the Company’s capital stock
(each a “Material Shareholder”), is presently a party to any transaction with the Company (other than
for services as employees, officers and directors), including any Contract providing for the furnishing of services to or by, providing
for rental of real or personal property to or from, or otherwise requiring payments to or from, any officer, director or such employee
or Material Shareholder or, to the best knowledge of the Company, any other Person in which any officer, director, or any such
employee or Material Shareholder has a substantial or material interest in or of which any officer, director or employee of the
Company or Material Shareholder is an officer, director, trustee or partner. There are no Claims or disputes of any nature or kind
between the Company and any officer, director or employee of the Company or any Material Shareholder, or between any of them, relating
to the Company and its business.

 

6.26Internal
Accounting Controls. Except as disclosed in the Company’s financial statements, the Company maintains a system of internal
accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance with management’s
general or specific authorizations; (ii) transactions are recorded as necessary to permit preparation of financial statements in
conformity with GAAP and to maintain asset accountability; (iii) access to Assets is permitted only in accordance with management’s
general or specific authorization; and (iv) the recorded accountability for Assets is compared with the existing Assets at reasonable
intervals and appropriate action is taken with respect to any differences.

 

6.27Acknowledgment
Regarding Buyer’s Purchase of the Securities. The Company and each Guarantor acknowledges and agrees that Buyer is acting
solely in the capacity of an arm’s length purchaser with respect to this Agreement and the transactions contemplated hereby.
The Company and each Guarantor further acknowledges that Buyer is not acting as a financial advisor or fiduciary of the Company
(or in any similar capacity) with respect to this Agreement and the transactions contemplated hereby and any advice given by Buyer
or any of its representatives or agents in connection with this Agreement and the transactions contemplated hereby is merely incidental
to Buyer’s purchase of the Securities. The Company further represents to Buyer that the Company’s and each Guarantor’s
decision to enter into this Agreement has been based solely on the independent evaluation by the Company, each Guarantor and its
representatives.

 

6.28Seniority.
No indebtedness or other equity or security of the Company and the Guarantors is senior to the Debentures in right of payment,
whether with respect to interest or upon liquidation or dissolution, or otherwise, except only purchase money security interests
(which are senior only as to underlying Assets covered thereby) and for $1,282,557.27 owed to the Internal Revenue Service.

 

    	18

     

    

 

6.29Brokerage
Fees. There is no Person acting on behalf of the Company and the Guarantors who is entitled to or has any claim for any brokerage
or finder’s fee or commission in connection with the execution of this Agreement or the consummation of the transactions
contemplated hereby.

 

6.30No
General Solicitation. Neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf, has engaged
in any form of general solicitation or general advertising (within the meaning of Regulation D under the Securities Act) in connection
with the offer or issuance of the Securities.

 

6.31No
Integrated Offering. Neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly
or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would
require registration of the Securities under the Securities Act or cause this offering of such securities to be integrated with
prior offerings by the Company for purposes of the Securities Act.

 

6.32Private
Placement. No registration under the Securities Act or the laws, rules or regulation of any other governmental authority is
required for the issuance of the Securities.

 

6.33Full
Disclosure. All the representations and warranties made by Company and the Guarantors herein or in the Schedules hereto, and
all of the financial statements, schedules, certificates, confirmations, agreements, contracts, and other materials submitted to
the Buyer in connection with or in furtherance of this Agreement or pertaining to the transaction contemplated herein, whether
made or given by Company and the Guarantors, its agents or representatives, are complete and accurate in all material respects,
and do not omit any information required to make the statements and information provided, in light of the transaction contemplated
herein and in light of the circumstances under which they were made, not misleading, accurate and meaningful.

 

ARTICLE VII

COVENANTS

 

7.1Negative
Covenants.

 

(a)Indebtedness.Except
for capital leases, so long as Buyer owns, legally or beneficially, any of the Debentures, the Company shall not, without the consent
of the Buyer which shall not be unreasonably withheld, either directly or indirectly, create, assume, incur or have outstanding
any indebtedness for borrowed money of any nature or kind (including purchase money indebtedness), or become liable, whether as
endorser, guarantor, surety or otherwise, for any Obligation of any other Person, except for: (i) the Debentures; (ii) Obligations
disclosed in the financial statements provided to the Buyer as of the Effective Date; and (iii) Obligations for accounts payable,
other than for money borrowed, incurred in the Company’s Ordinary Course of Business; provided that, any management or similar
fees payable by the Company shall be fully subordinated in right of payment to the prior payment in full of the Debentures.

    	19

     

    

 

(b)Encumbrances.Except
for purchase money security interests and capital leases, so long as Buyer owns, legally or beneficially, any of the Debentures,
the Company and the Guarantors shall not, either directly or indirectly, create, assume, incur or suffer or permit to exist any
Encumbrance upon any Asset of the Company and the Guarantors, whether owned at the date hereof or hereafter acquired.

 

(c)Investments.Except
for acquisitions and mergers specified in Schedule 7.1(c) following notice to the Buyer and for the Merger, so long as Buyer owns,
legally or beneficially, any of the Debentures, the Company shall not, either directly or indirectly, make or have outstanding
any new investments (whether through purchase of stocks, obligations or otherwise) in, or loans or advances to, any other Person,
or acquire all or any substantial part of the assets, business, stock or other evidence of beneficial ownership of any other Person,
except the following: (i) investments in direct obligations of the United States or any state in the United States; (ii) trade
credit extended by the Company in the Company’s Ordinary Course of Business; (iii) investments existing on the Effective
Date and set forth in the financial statements provided to the Buyer; (iv) capital expenditures first approved by the Buyer in
writing, which approval shall not be unreasonably withheld; and (v) other mergers and acquisitions approved by the Buyer in writing,
which approval shall not be unreasonably withheld.

 

(d)Issuances.
So long as Buyer owns, legally or beneficially, any of the Debentures, the Company shall not, either directly or indirectly, issue
any equity, debt or convertible or derivative instruments or securities whatsoever, except upon obtaining Buyer’s prior written
consent, which consent may be withheld in Buyer’s sole discretion; provided however, notwithstanding anything to the contrary,
the Company shall be permitted to issue equity, convertible or derivative instruments, if following the issuance of such equity,
convertible or derivative instruments, there does not result in a Change of Control, .

 

(e)Transfer;
Merger. Except in connection with the Merger, so long as Buyer owns, legally or beneficially, any of the Debentures, the Company
shall not, either directly or indirectly, permit or enter into any transaction involving a “Change in Control” (as
hereinafter defined), or any other merger, consolidation, sale, transfer, license, Lease, Encumbrance or other disposition of all
or substantially all of its properties or business or all or substantially all of its Assets, except for the sale, lease or licensing
of property or Assets of the Company in the Company’s Ordinary Course of Business. For purposes of this Agreement, the term
“Change of Control” shall mean any sale, conveyance, assignment or other transfer, directly or indirectly, of
any ownership interest of the Company which results in any change in the identity of the individuals or entities previously having
the power to direct, or cause the direction of, the management and policies of the Company, or the grant of a security interest
in any ownership interest of any Person directly or indirectly controlling the Company, which could result in a change in the identity
of the individuals or entities previously having the power to direct, or cause the direction of, the management and policies of
the Company.

 

    	20

     

    

 

(f)Distributions;
Restricted Payments; Change in Management. So long as Buyer owns, legally or beneficially, any of the Debentures, the Company
shall not, either directly or indirectly: (i) purchase or redeem any shares of its capital stock; (ii) pay any dividends or distributions,
whether in cash or otherwise, or set aside any funds for any such purpose; (iii) make any distribution to its shareholders, make
any distribution of its property or Assets or make any loans, advances or extensions of credit to, or investments in, any Person,
including, without limitation, any Affiliates of the Company, or the Company’s officers, directors, employees or Material
Shareholder; (iv) pay any outstanding indebtedness of the Company, except for indebtedness and other Obligations permitted hereunder;
(v) increase the annual salary paid to any officer of the Company as of the Effective Date by more than twenty-five percent (25%)
of the amount of such officer’s current salary as disclosed to the Buyer as of the date hereof or directors of the Company
as of the Effective Date; provided, however, the Company shall be able to increase salaries of such directors by an amount not
to exceed Two Hundred Thousand Dollars ($200,000) in the aggregate; or (vi) add, replace, remove, or otherwise change any officers
or other senior management positions of the Company without prior written notice to the Buyer. The Company shall not pay any brokerage
or finder’s fee or commission in connection with the execution of this Agreement or the consummation of the transactions
contemplated hereby

 

(g)Use
of Proceeds. The Company shall not use any portion of the proceeds of the Debentures, either directly or indirectly, for any
of the following purposes: (i) to make any payment towards any indebtedness or other Obligations of the Company; (ii) to pay any
Taxes of any nature or kind that may be due by the Company without the prior consent of the Buyer; or (iii) to pay any Obligations
of any nature or kind due or owing to any officers, directors, employees, or Material Shareholders of the Company, other than salaries
payable in the Company’s Ordinary Course of Business. The Company covenants and agrees to only use any portion of the proceeds
of the purchase and sale of the Debentures for the purposes set forth in the Use of Proceeds Confirmation to be executed by the
Company on the Effective Date, unless the Company obtains the prior written consent of the Buyer to use such proceeds for any other
purpose, which consent may be granted or withheld or conditioned by Buyer in its sole and absolute discretion. Notwithstanding
anything to the contrary in this Agreement and/or the Use of Proceeds Confirmation, the Company shall not use any portion of the
proceeds of the Debentures for offshore operations without the prior consent of the Buyer until Platinum Financial Solutions Ltd.
shall become an additional party hereto and guarantor of the Company’s Obligation hereunder pursuant to Section 7.11.

 

(h)Business
Activities; Change of Legal Status and Organizational Documents. The Company shall not: (i) engage in any line of business
other than the businesses engaged in as of the Effective Date and business reasonably related thereto; (ii) change its name, organizational
identification number (if applicable), its type of organization, its jurisdiction of organization or other legal structure; or
(iii) permit its Certificate of Incorporation, Bylaws or other organizational documents to be amended or modified in any way which
could reasonably be expected to have a Material Adverse Effect; provided, however, in connection with the Merger or any other mergers,
the foregoing is permitted upon fifteen (15) days’ prior written notice to the Buyer.

 

    	21

     

    

 

(i)Transactions
with Affiliates. The Company shall not enter into any transaction with any of its Affiliates, officers, directors, employees,
Material Shareholders or other insiders, except in the Company’s Ordinary Course of Business and upon fair and reasonable
terms that are no less favorable to the Company than it would obtain in a comparable arm’s length transaction with a Person
not an Affiliate of the Company.

 

(j)Bank
Accounts. The Company shall not maintain any bank, deposit, credit card payment processing accounts, or other accounts with
any financial institution, or any other Person, other than the Company’s accounts listed in the attached Schedule 6.22.
Specifically, the Company may not change, modify, close or otherwise affect any of the accounts listed in Schedule 6.22
without Buyer’s prior written approval, which approval may be withheld or conditioned in Buyer’s sole and absolute
discretion.

 

 7.2 Affirmative Covenants.

 

(a)Corporate
Existence. The Company shall at all times preserve and maintain its: (i) existence and good standing in the jurisdiction of
its organization; and (ii) its qualification to do business and good standing in each jurisdiction where the nature of its business
makes such qualification necessary, and shall at all times continue as a going concern in the business which the Company is presently
conducting.

 

(b)Tax
Liabilities. The Company and the Guarantors shall at all times pay and discharge all Taxes upon, and all Claims (including
claims for labor, materials and supplies) against the Company or any of its properties or Assets, before the same shall become
delinquent and before penalties accrue thereon, unless and to the extent that the same are being contested in good faith by appropriate
proceedings and for which adequate reserves in accordance with GAAP are being maintained.

 

(c)Notice
of Proceedings. The Company shall, promptly, but not more than five (5) days after knowledge thereof shall have come to the
attention of any officer of the Company, give written notice to the Buyer of all material threatened or pending Proceedings before
any Governmental Authority or otherwise materially and adversely affecting the Company or any of its Assets.

 

(d)Material
Adverse Effect. The Company shall, promptly, but not more than five (5) days after knowledge thereof shall have come to the
attention of any officer of the Company, give written notice to the Buyer of any event, circumstance, fact or other matter that
could in any way have or be reasonably expected to have a Material Adverse Effect.

 

(e)Notice
of Default. The Company shall, promptly, but not more than five (5) days after the commencement thereof, give notice to the
Buyer in writing of the occurrence of any “Event of Default” (as such term is defined in any of the Transaction Documents)
or of any event which, with the lapse of time, the giving of notice or both, would constitute an Event of Default hereunder or
under any other Transaction Documents.

 

    	22

     

    

 

(f)Maintain
Property. The Company shall at all times maintain, preserve and keep all of its Assets in good repair, working order and condition,
normal wear and tear excepted, and shall from time to time, as the Company deems appropriate in its reasonable judgment, make all
needful and proper repairs, renewals, replacements, and additions thereto so that at all times the efficiency thereof shall be
fully preserved and maintained. The Company shall permit Buyer to examine and inspect such Assets at all reasonable times upon
reasonable notice during business hours. During the continuance of any Event of Default hereunder or under any Transaction Documents,
the Buyer shall, at the Company’s expense, have the right to make additional inspections without providing advance notice.

 

(g)Maintain
Insurance. The Company shall at all times insure and keep insured with insurance companies acceptable to Buyer, all insurable
property owned by the Company which is of a character usually insured by companies similarly situated and operating like properties,
against loss or damage from environmental, fire and such other hazards or risks as are customarily insured against by companies
similarly situated and operating like properties; and shall similarly insure employers’, public and professional liability
risks. Prior to the Effective Date, the Company shall deliver to the Buyer a certificate setting forth in summary form the nature
and extent of the insurance maintained pursuant to this Section. All such policies of insurance must be satisfactory to Buyer in
relation to the amount and term of the Debentures and type and value of the Assets of the Company, shall identify Buyer as sole/lender’s
loss payee, except for leased equipment, and as an additional insured. In the event the Company fails to provide Buyer with evidence
of the insurance coverage required by this Section or at any time hereafter shall fail to obtain or maintain any of the policies
of insurance required above, or to pay any premium in whole or in part relating thereto, then the Buyer, without waiving or releasing
any obligation or default by the Company hereunder, may at any time after written notice to the Company and a right to cure (but
shall be under no obligation to so act), obtain and maintain such policies of insurance and pay such premium and take any other
action with respect thereto, which Buyer deems advisable. This insurance coverage: (i) may, but need not, protect the Company’s
interest in such property; and (ii) may not pay any claim made by, or against, the Company in connection with such property. The
Company may later request that the Buyer cancel any such insurance purchased by Buyer, but only after providing Buyer with evidence
that the insurance coverage required by this Section is in force. The costs of such insurance obtained by Buyer, through and including
the effective date such insurance coverage is canceled or expires, shall be payable on demand by the Company to Buyer, together
with interest at the highest non-usurious rate permitted by law on such amounts until repaid and any other out of pocket charges
by Buyer in connection with the placement of such insurance. The costs of such insurance, which may be greater than the cost of
insurance which the Company may be able to obtain on its own, together with interest thereon at the highest non-usurious rate permitted
by Law and any other out of pocket charges incurred by Buyer in connection with the placement of such insurance may be added to
the total Obligations due and owing by the Company hereunder and under the Debentures to the extent not paid by the Company.

 

    	23

     

    

 

(h)ERISA
Liabilities; Employee Plans. The Company shall: (i) keep in full force and effect any and all Employee Plans which are presently
in existence or may, from time to time, come into existence under ERISA, and not withdraw from any such Employee Plans, unless
such withdrawal can be effected or such Employee Plans can be terminated without liability to the Company; (ii) make contributions
to all of such Employee Plans in a timely manner and in a sufficient amount to comply with the standards of ERISA, including the
minimum funding standards of ERISA; (iii) comply with all material requirements of ERISA which relate to such Employee Plans; (iv)
notify Buyer immediately upon receipt by the Company of any notice concerning the imposition of any withdrawal liability or of
the institution of any Proceeding or other action which may result in the termination of any such Employee Plans or the appointment
of a trustee to administer such Employee Plans; (v) promptly advise Buyer of the occurrence of any “Reportable Event”
or “Prohibited Transaction” (as such terms are defined in ERISA), with respect to any such Employee Plans; and (vi)
amend any Employee Plan that is intended to be qualified within the meaning of Section 401 of the Internal Revenue Code of 1986
to the extent necessary to keep the Employee Plan qualified, and to cause the Employee Plan to be administered and operated in
a manner that does not cause the Employee Plan to lose its qualified status.

 

(i)Reporting
Status; Listing. So long as Buyer owns, legally or beneficially, any of the Securities, the Company shall prior to the Merger:
(i) file in a timely manner (within permissible extension periods) all reports required to be filed under the Securities Act, the
Exchange Act or any securities Laws and regulations thereof applicable to the Company of any state of the United States, or by
the rules and regulations of the Principal Trading Market, and, to provide a copy thereof to the Buyer promptly after such filing;
(ii) not terminate its status as an issuer required to file reports under the Exchange Act even if the Exchange Act or the rules
and regulations thereunder would otherwise permit such termination; (iii) if required by the rules and regulations of the Principal
Trading Market, promptly secure the listing of any shares of Common Stock issuable to Buyer under any of the Transaction Documents
upon the Principal Trading Market (subject to official notice of issuance) and, take all reasonable action under its control to
maintain the continued listing, quotation and trading of its Common Stock (including, without limitation, any shares of Common
Stock issuable to Buyer under any of the Transaction Documents) on the Principal Trading Market, and the Company shall comply in
all respects with the Company’s reporting, filing and other Obligations under the bylaws or rules of the Principal Trading
Market, the Financial Industry Regulatory Authority, Inc. and such other Governmental Authorities, as applicable. The Company shall
prior to the Merger promptly provide to Buyer copies of any notices it receives from the SEC or any Principal Trading Market, to
the extent any such notices could in any way have or be reasonably expected to have a Material Adverse Effect.

 

(j)Rule
144. With a view to making available to Buyer the benefits of Rule 144 under the Securities Act (“Rule 144”),
or any similar rule or regulation of the SEC that may at any time permit Buyer to sell shares of Common Stock prior to the
Merger issuable to Buyer under any Transaction Documents to the public without registration, the Company represents and warrants
that:

 

    	24

     

    

 

(i) the
Company is, and has been for a period of at least ninety (90) days immediately preceding the date hereof, subject to the reporting
requirements of Section 13 or 15(d) of the Exchange Act; (ii) the Company has filed all required reports under Section 13 or 15(d)
of the Exchange Act, as applicable, during the twelve (12) months preceding the First Closing Date (or for such shorter period
that the Company was required to file such reports); and (iii) the Company is not currently an issuer defined as a “Shell
Company” (as hereinafter defined). For the purposes hereof, the term “Shell Company” shall mean an issuer
that meets such a description as defined under Rule 144. In addition, so long as Buyer owns, legally or beneficially, any securities
of the Company, the Company shall prior to the Merger, at its sole expense:

 

(ii)Prior
to the Merger, make, keep and ensure that adequate current public information with respect to the Company, as required in accordance
with Rule 144, is publicly available; 

 

(iii)Prior
to the Merger, furnish to the Buyer, promptly upon reasonable request: (A) a written statement by the Company that it has complied
with the reporting requirements of Rule 144, the Securities Act and the Exchange Act; and (b) such other information as may be
reasonably requested by Buyer to permit the Buyer to sell any of the shares of Common Stock acquired hereunder or under any other
Transaction Documents pursuant to the provisions of Rule 144; and

 

(iv)Prior
to the Merger, promptly at the request of Buyer, give the Company’s transfer agent (the “Transfer Agent”)
instructions to the effect that, upon the Transfer Agent’s receipt from Buyer of a certificate (a “Rule 144
Certificate”) certifying that Buyer’s holding period (as determined in accordance with the provisions of
Rule 144) for any portion of the shares of Common Stock issuable under any Transaction Document which Buyer proposes to sell (or
any portion of such shares which Buyer is not presently selling, but for which Buyer desires to remove any restrictive legends
applicable thereto if Buyer’s holding period is not less than twelve (12) months) (the “Securities Being Sold”)
is not less than six (6) months, and receipt by the Transfer Agent of the “Rule 144 Opinion” (as hereinafter defined)
from the Company or its counsel (or from Buyer and its counsel as permitted below), the Transfer Agent is to effect the transfer
(or issuance of a new certificate without restrictive legends, if applicable) of the Securities Being Sold and issue to Buyer or
transferee(s) thereof one or more stock certificates representing the transferred (or re-issued) Securities Being Sold without
any restrictive legend and without recording any restrictions on the transferability of such shares on the Transfer Agent’s
books and records. In this regard, upon Buyer’s request, the Company shall have an affirmative obligation to cause its counsel
to promptly issue to the Transfer Agent a legal opinion providing that, based on the Rule 144 Certificate, the Securities Being
Sold may be sold pursuant to the provisions of Rule 144, even in the absence of an effective registration statement (the “Rule
144 Opinion”). If the Transfer Agent requires any additional documentation in connection with any proposed transfer
(or re-issuance) by Buyer of any Securities Being Sold, the Company shall promptly deliver or cause to be delivered to the Transfer
Agent or to any other Person, all such additional documentation as may be necessary to effectuate the transfer (or re issuance)
of the Securities Being Sold and the issuance of an unlegended certificate to any such Buyer or any transferee thereof, all at
the Company’s expense. Any and all reasonable fees, charges or expenses, including, without limitation, attorneys’
fees and costs, incurred by Buyer in connection with issuance of any such shares, or the removal of any restrictive legends thereon,
or the transfer of any such shares to any assignee of Buyer, shall be paid by the Company, and if not paid by the Company, the
Buyer may, but shall not be required to, pay any such fees, charges or expenses, and the amount thereof, together with interest
thereon at the highest non-usurious rate permitted by law, from the date of outlay, until paid in full, shall be due and payable
by the Company to Buyer promptly upon demand therefor, and all such amounts shall be additional Obligations of the company to Buyer
secured under the Transaction Documents. In the event that the Company and/or its counsel refuses or fails for any reason to render
the Rule 144 Opinion or any other documents, certificates or instructions required to effectuate the transfer (or re-issuance)
of the Securities Being Sold and the issuance of an unlegended certificate to any such Buyer or any transferee thereof, then: (A)
to the extent the Securities Being Sold could be lawfully transferred (or re-issued) without restrictions under applicable laws,
Company’s failure to promptly provide the Rule 144 Opinion or any other documents, certificates or instructions required
to effectuate the transfer (or re-issuance)of the Securities Being Sold and the issuance of an unlegended certificate to any such
Buyer or any transferee thereof shall be an immediate Event of Default under this Agreement and all other Transaction Documents;
and (B) the Company hereby agrees and acknowledges that Buyer is hereby irrevocably and expressly authorized to have counsel to
Buyer render any and all opinions and other certificates or instruments which may be required for purposes of effectuating the
transfer (or re-issuance) of the Securities Being Sold and the issuance of an unlegended certificate to any such Buyer or any transferee
thereof, and the Company hereby irrevocably authorizes and directs the Transfer Agent to, without any further confirmation or instructions
from the Company, transfer or re-issue any such Securities Being Sold as instructed by Buyer and its counsel.

 

    	25

     

    

 

(k)Matters
With Respect to Securities.

 

(i)Issuance
of Conversion Shares.The parties hereto acknowledge that pursuant to the terms of the Debentures, Buyer has the right,
at its discretion following an Event of Default, to convert amounts due under the Debentures into Common Stock in accordance with
the terms of the Debentures. In the event, for any reason, the Company fails to issue, or cause its Transfer Agent to issue, any
portion of the Common Stock issuable upon conversion of the Debentures (the “Conversion Shares”) to Buyer
in connection with the exercise by Buyer of any of its conversion rights under the Debentures, then the parties hereto acknowledge
that Buyer shall irrevocably be entitled to deliver to the Transfer Agent, on behalf of itself and the Company, a “Conversion
Notice” (as defined in the Debentures) requesting the issuance of the Conversion Shares then issuable in accordance with
the terms of the Debentures, and the Transfer Agent, provided they are the acting transfer agent for the Company at the time, shall,
and the Company hereby irrevocably authorizes and directs the Transfer Agent to, without any further confirmation or instructions
from the Company, issue the Conversion Shares applicable to the Conversion Notice then being exercised, and surrender to a nationally
recognized overnight courier for delivery to Buyer at the address specified in the Conversion Notice, a certificate of the Common
Stock of the Company, registered in the name of Buyer or its nominee, for the number of Conversion Shares to which Buyer shall
be then entitled under the Debentures, as set forth in the Conversion Notice.

 

    	26

     

    

 

(ii)Removal
of Restrictive Legends. In the event that Buyer has any shares of the Company’s Common Stock bearing any restrictive
legends, and Buyer, through its counsel or other representatives, submits to the Transfer Agent any such shares for the removal
of the restrictive legends thereon, in connection with a sale of such shares pursuant to an applicable exemption to the
registration requirements under the Securities Act, or in the absence of a sale pursuant to the provisions of Rule 144, and the
Company and or its counsel refuses or fails for any reason to render an opinion of counsel or any other documents or certificates
required for the removal of the restrictive legends, then the Company hereby agrees and acknowledges that Buyer is hereby irrevocably
and expressly authorized to have counsel to Buyer render any and all opinions and other certificates or instruments which may be
required for purposes of removing such restrictive legends, and the Company hereby irrevocably authorizes and directs the Transfer
Agent to, without any further confirmation or instructions from the Company, issue any such shares without restrictive legends
as instructed by Buyer, and surrender to a common carrier for overnight delivery to the address as specified by Buyer, certificates,
registered in the name of Buyer or its designees or nominees, representing the shares of Common Stock to which Buyer is entitled,
without any restrictive legends and otherwise freely transferable on the books and records of the Company.

 

(iii)Authorized
Agent of the Company. The Company hereby irrevocably appoints the Buyer and its counsel and its representatives, each as the
Company’s duly authorized agent and attorney-in-fact for the Company for the purposes of authorizing and instructing the
Transfer Agent to process issuances, transfers and legend removals upon instructions from Buyer, or any counsel or representatives
of Buyer, as specifically contemplated herein. The authorization and power of attorney granted hereby is coupled with an interest
and is irrevocable so long as any obligations of the Company under Debentures remain outstanding, and so long as the Buyer owns
or has the right to receive, any shares of the Company’s Common Stock hereunder or under any Transaction Documents. In this
regard, the Company hereby confirms to the Transfer Agent and the Buyer that it can NOT and will NOT give instructions,
including stop orders or otherwise, inconsistent with the terms of this Agreement with regard to the matters contemplated herein,
and that the Buyer shall have the absolute right to provide a copy of this Agreement to the Transfer Agent as evidence of the Company’s
irrevocable authority for Buyer and Transfer Agent to process issuances, transfers and legend removals upon instructions from Buyer,
or any counsel or representatives of Buyer, as specifically contemplated herein, without any further instructions, orders or confirmations
from the Company.

 

(iv)Injunction
and Specific Performance. The Company specifically acknowledges and agrees that in the event of a breach or threatened breach
by the Company of any provision of this Section 7.2(k), the Buyer will be irreparably damaged and that damages at law would
be an inadequate remedy if this Agreement were not specifically enforced. Therefore, in the event of a breach or threatened breach
of any provision of this Section 7.2(k) by the Company, the Buyer shall be entitled to obtain, in addition to all other
rights or remedies Buyer may have, at law or in equity, an injunction restraining such breach, without being required to show any
actual damage or to post any bond or other security, and/or to a decree for specific performance of the provisions of this Section
7.2(k).

 

    	27

     

    

 

(l)Continued
Due Diligence/Field Audits. The Company acknowledges that during the term of this Agreement, Buyer and its agents and representatives
undertake ongoing and continuing due diligence reviews of the Company and its business and operations. Such ongoing due diligence
reviews may include, and the Company does hereby agree to allow Buyer up to two (2) times per year pre-Event of Default, to conduct
site visits and field examinations of the office locations of the Company, and the Assets and records of each of them, the results
of which must be satisfactory to Buyer in Buyer’s reasonable discretion. In this regard, in order to cover Buyer’s
expenses of the ongoing due diligence reviews and any site visits or field examinations which Buyer may undertake from time to
time while this Agreement is in effect, the Company shall pay to Buyer, within five (5) Business Days after receipt of an invoice
or demand therefor from Buyer, a fee of up to $5,000 per year (based on two (2) expected field audits and ongoing due diligence
of $2,500 per visit or audit) to cover such ongoing expenses. Failure to pay such fee as and when required shall be deemed an Event
of Default under this Agreement and all other Transaction Documents. The foregoing notwithstanding, during a continuing Event of
Default, Buyer may conduct site visits, field examinations and other ongoing reviews of the Company’s records, Assets and
operations at any time, in its sole discretion, without any limitations in terms of number of site visits or examinations and without
being limited to the fee hereby contemplated, all at the sole expense of the Company.

 

7.3Reporting
Requirements. The Company agrees as follows:

 

(a)Financial
Statements. The Company shall at all times maintain a system of accounting capable of producing its individual and consolidated
(if applicable) financial statements in compliance with GAAP (provided that monthly financial statements shall not be required
to have footnote disclosure, are subject to normal year-end adjustments and need not be consolidated), and shall furnish to the
Buyer or its authorized representatives such information regarding the business affairs, operations and financial condition of
the Company as Buyer may from time to time reasonably request or require, including:

 

(i)As
soon as available, and in any event, within one hundred five (105) days after the close of each fiscal year, a copy of the annual
audited financial statements of the Company, including balance sheet, statement of income and retained earnings, statement of cash
flows for the fiscal year then ended, in reasonable detail, prepared and reviewed by an independent certified public accountant
reasonably acceptable to Buyer, containing an unqualified opinion of such accountant;

 

(ii)as
soon as available, and in any event, within sixty (60) days after the close of each fiscal quarter, a copy of the quarterly financial
statements of the Company, including balance sheet, statement of income and retained earnings, statement of cash flows for the
fiscal year then ended, in reasonable detail, prepared and certified as accurate in all material respects by the CEO or CFO of
the Company;

 

(iii)as
soon as available, and in any event, within thirty (30) days following the end of each calendar month, a copy of the financial
statements of the Company regarding such month, including balance sheet, statement of income and retained earnings, statement of
receipts and disbursements for the month then ended, in reasonable detail, prepared and certified as accurate in all material respects
by the CEO or CFO of the Company.

 

    	28

     

    

 

No change with
respect to the Company’s accounting principles shall be made by the Company without giving prior notification to Buyer. The
Company represents and warrants to Buyer that the financial statements delivered to Buyer at or prior to the execution and delivery
of this Agreement and to be delivered at all times thereafter accurately reflect and will accurately reflect the financial condition
of the Company in all material respects. Buyer shall have the right at all times (and on reasonable notice so long as there then
does not exist any continuing Event of Default) during business hours to inspect the books and records of the Company and make
extracts therefrom.

 

(b)Additional
Reporting Requirements. The Company shall provide the following reports and statements to Buyer as follows:

 

(i)Income
Projections; Variance. On the Effective Date, the Company shall provide to Buyer an income statement projection showing, in
reasonable detail, the Company’s income statement projections for the twelve (12) calendar months following the Effective
Date (the “Income Projections”). In addition, on the twenty-first (21st) day of every calendar
month after the Effective Date, the Company shall provide to Buyer a report comparing the Income Projections to actual results.
Any variance in the Income Projections to actual results that is more than ten percent (10%) (either above or below) will require
the Company to submit to Buyer written explanations as to the nature and circumstances for the variance.

 

(ii)Use
of Proceeds; Variance. On the twenty-first (21st) day of every calendar month after the Effective Date, the Company shall provide
to Buyer a report comparing the use of the proceeds from the sale of Debentures set forth in the Use of Proceeds Confirmation,
with the actual use of such proceeds. Any variance in the actual use of such proceeds from the amounts set forth in the approved
Use of Proceeds Confirmation will require the Company to submit to Buyer written explanations as to the nature and circumstances
for the variance.

 

(iii)Bank
Statements. The Company shall submit to Buyer true and correct copies of all bank statements received by the Company within
five (5) days after the Company’s receipt thereof from its bank.

 

(iv)Interim
Reports. Promptly upon receipt thereof, the Company shall provide to Buyer copies of interim and supplemental reports,
if any, submitted to the Company by independent accountants in connection with any interim audit or review of the books of the
Company.

 

    	29

     

    

 

(v)Aged
Accounts/Payables Schedules. The Company shall, on the tenth (10th) day of each and every calendar month, deliver
to Buyer an aged schedule of the accounts receivable of the Company, listing the name and amount due from each Person and showing
the aggregate amounts due from: (i) 0-30 days; (ii) 31-60 days; (iii) 61-90 days; (iv) 91-120 days; and (v) more than 120 days,
and certified as accurate by the CEO or CFO of the Company. The Company shall, on the first (1st) day of each and every
calendar month, deliver to Buyer an aged schedule of the accounts payable of the Company, listing the name and amount due to each
creditor and showing the aggregate amounts due from: (v) 0-30 days; (w) 31-60 days; (x) 61-90 days; (y) 91-120 days; and (z) more
than 120 days, and certified as accurate by the CEO or CFO of the Company.

 

(vi)View
Only Access. The Company and each Guarantor shall provide Buyer view only access to any and all accounts listed on the attached
Schedule 6.22.

 

(c)Failure
to Provide Reports. So long as Buyer owns, legally or beneficially, any of the Securities, if the Company shall fail to timely
provide any reports required to be provided by the Company and/or Guarantors to the Buyer under this Agreement or any other Transaction
Document, in addition to all other rights and remedies that Buyer may have under this Agreement and the other Transaction Documents,
Buyer shall have the right to require, at each instance of any such failure, upon fourteen (14) day written notice to the Company
and cure period, that the Company redeem 2.5% of the aggregate amount of the Advisory Fee then outstanding, which cash redemption
payment shall be due and payable by wire transfer of Dollars to an account designated by Buyer within five (5) Business Days from
the date the Buyer delivers such redemption notice to the Company. The parties hereto acknowledge and agree that the first failure
under this Section shall not constitute an Event of Default as set forth in the Debenture and incorporated by reference herein.

 

(d)Covenant
Compliance. The Company shall, within thirty (30) days after the end of each calendar month, deliver to Buyer a Compliance
Certificate, confirming compliance by the Company with the covenants therein, and certified as accurate by an officer of
the Company.

 

7.4Fees
and Expenses.

 

(a)Transaction
Fees. The Company agrees to pay to Buyer a transaction advisory fee equal to four percent (4%) of the amount of the Debentures
purchased by Buyer at the First Closing, which fee shall be due and payable on the Effective Date and withheld from the gross purchase
price paid by Buyer for the Debentures. In the event of any Additional Closings, the Company shall pay to Buyer a transaction advisory
fee equal to two percent (2%) of the amount of the Debentures purchased by Buyer at any such Additional Closings, which fee shall
be due and payable upon such Additional Closing and withheld from the gross purchase price paid by Buyer for the Debentures at
such Additional Closing.

 

(b)Due
Diligence Fees. The Company agrees to pay to the Buyer a due diligence fee equal to Seven Thousand Five Hundred and No/100
United States Dollars ($7,500.00), which shall be due and payable in full on the Effective Date, or any remaining portion thereof
shall be due and payable on the Effective Date if a portion of such fee was paid upon the execution of any term sheet related to
this Agreement.

 

    	30

     

    

 

(c)Document
Review and Legal Fees. The Company agrees to pay to the Buyer or its counsel a document review and legal fee equal to Twenty
Thousand and No/100 United States Dollars ($20,000.00), which shall be due and payable in full on the Effective Date, or any remaining
portion thereof shall be due and payable on the Effective Date if a portion of such fee was paid upon the execution of any term
sheet related to this Agreement. The Company also agrees to be responsible for the prompt payment of all legal fees and expenses
of the Company and its own counsel and other professionals incurred by the Company in connection with the negotiation and execution
of this Agreement and the Transaction Documents.

 

(d)Other
Fees. The Company also agrees to pay to the Buyer (or any designee of the Buyer), upon demand, or to otherwise be responsible
for the payment of, any and all other costs, fees and expenses, including the reasonable fees, costs, expenses and disbursements
of counsel for the Buyer and of any experts and agents, which the Buyer may incur or which may otherwise be due and payable in
connection with: (i) the preparation, negotiation, execution, delivery, recordation, administration, amendment, subordination,
waiver or other modification or termination of this Agreement or any other Transaction Documents; (ii) any documentary stamp taxes,
intangibles taxes, recording fees, filing fees, or other similar taxes, fees or charges imposed by or due to any Governmental Authority
in connection with this Agreement or any other Transaction Documents; (iii) the exercise or enforcement of any of the rights of
the Buyer under this Agreement or the Transaction Documents; or (iv) the failure by the Company to perform or observe any of the
provisions of this Agreement or any of the Transaction Documents. Included in the foregoing shall be the amount of all reasonable
expenses paid or incurred by Buyer in consulting with counsel concerning any of its rights under this Agreement or any other Transaction
Document or under applicable law. To the extent any such costs, fees, charges, taxes or expenses are incurred prior to the funding
of proceeds from the Closing, same shall be paid directly from the proceeds of the Closing. All such costs and expenses, if not
so immediately paid when due or upon demand thereof, shall bear interest from the date of outlay until paid, at the highest rate
set forth in the Debenture, or if none is so stated, the highest rate allowed by law. All of such costs and expenses shall be additional
Obligations of the Company to Buyer secured under the Transaction Documents. The provisions of this Subsection shall survive the
termination of this Agreement.

 

7.5Advisory
Fee. The Company hereby acknowledges that it has obligations to the Buyer for advisory services provided by the Buyer to the
Company prior to the Effective Date in the amount of Three Hundred Thousand and No/100 United States Dollars (US$300,000.00) (the
“Advisory Fee”). In this regard, the Company shall redeem the Advisory Fee obligations in three (3) equal installments,
each in the amount of One Hundred Thousand and No/100 United States Dollars (US$100,000.00), each of such redemption installments
to be paid by Company in Dollars by wire transfer to an account designated by Buyer, the first installment due on a date that is
nine (9) months from the Effective Date, the second installment due on a date that is twelve (12) months from the Effective Date,
and the third installment due on a date that is sixteen (16) months from the Effective Date, without further claim, notice or demand
from the Buyer. The obligation to redeem the Advisory Fee obligations contemplated by this Section 7.5 shall be an Obligation hereunder,
secured by all Transaction Documents, and failure by the Company to timely make any of such redemption payments when due as hereby
provided shall be an immediate Event of Default hereunder and under the other Transactions Documents. The Advisory Fees contemplated
by this Section 7.5 have been fully earned by Buyer prior to the date hereof, and the Company’s obligation to redeem such
Advisory Fee obligations as hereby provided shall be applicable and effective regardless of whether any additional Debentures are
purchased hereunder.  In the event the Buyer elects to purchase any additional Debentures as permitted by this Agreement,
the Company agrees to pay additional advisory service fees to the Buyer in an amount to be mutually agreed upon between the Company
and Buyer.

 

    	31

     

    

 

7.6Surviving
Obligations. The Company agrees and acknowledges that notwithstanding the termination of this Agreement, or the payment in
full of all of the Debentures or other obligations hereunder or under any other Transaction Documents, the Company’s obligations
and liability under this Agreement and the other Transaction Documents, and the Buyer’s security interest on all Collateral,
shall remain valid and effective and shall not be released or terminated, until the Company has fully redeemed all Advisory Fee
obligations in accordance with the terms hereof, together with all other Obligations. All of the Company’s obligations under
Section 7.5 shall survive termination of this Agreement.

 

7.7Right
to Approve Transfer Agent. The Company hereby represents and warrants that the Company’s current Transfer Agent is Island
Stock Transfer, whose contact information is as follows: 15500 Roosevelt Blvd., Suite 301, Clearwater, FL 33760, Attn: Katie Messinger,
Email: kmessinger@islandstocktransfer.com. The Company hereby agrees that it shall not change the Transfer Agent, unless the Buyer
first received notice of the proposed new Transfer Agent.

 

7.8Share
Reserve. The Company represents that it has sufficient authorized and unissued shares of Common Stock available to effect the
issuance of the Conversion Shares under this Agreement or any other Transaction Documents (collectively, the “Share Reserve”)
after considering all other commitments that may require the issuance of Common Stock. The Company shall take all action reasonably
necessary to at all times have authorized, and reserved for the purpose of issuance, such number of shares of Common Stock as shall
be necessary to effect the full conversion of the Debentures that may be issuable hereunder. If upon receipt of a conversion notice
from the Buyer, the Share Reserve is insufficient to effect the full conversion of the Debentures that may be issuable hereunder,
the Company shall take all required measures to implement an increase of the Share Reserve accordingly. If the Company does not
have sufficient authorized and unissued shares of Common Stock available to increase the Share Reserve, the Company shall, on receipt
of a notice of conversion, cause its authorized and unissued shares to be increased within forty-five (45) days to an amount of
shares equal to three (3) times the Conversion Shares.

 

7.9Subsidiaries.
Any Subsidiary which is formed or acquired or otherwise becomes a Subsidiary of the Company following the date hereof, within ten
(10) Business Days of such event, shall become an additional party hereto and guarantor of the Company’s Obligation hereunder,
and the Company shall take any and all actions necessary or advisable to cause said Subsidiary to execute a counterpart to this
Agreement and any and all other documents which the Buyer shall require. “Subsidiary” shall mean, respectively,
each and all such corporations, partnerships, limited partnerships, limited liability companies, limited liability partnerships
or other entities of which or in which a Person owns, directly or indirectly, fifty percent (50%) or more of: (i) the combined
voting power of all classes of stock/units having general voting power under ordinary circumstances to elect a majority of the
board of directors of such entity if a corporation; (ii) the management authority and capital interest or profits interest of such
entity, if a partnership, limited partnership, limited liability company, limited liability partnership, joint venture or similar
entity; or (iii) the beneficial interest of such entity, if a trust, association or other unincorporated organization. This Section
7.9 shall apply to CollabRx, Inc. 

 

    	32

     

    

 

7.10Merger.
Within ten (10) Business Day upon completion of the Merger, CollabRx, Inc. shall become an additional party hereto and guarantor
of the Company’s Obligation hereunder, and the Company shall take any and all actions necessary or advisable to cause CollabRx,
Inc. to execute a counterpart to this Agreement and any and all other documents which the Buyer shall require.

 

7.11Platinum
Financial Solutions. Within fifteen (15) Business Days from the Closing Date, Platinum Financial Solutions Ltd., a limited
company organized and existing under the laws of the Bahamas, shall become an additional party hereto and guarantor of the Company’s
Obligation hereunder, and shall execute a counterpart to this Agreement and any and all other documents which the Buyer shall require.

 

ARTICLE VIII

CONDITIONS PRECEDENT TO THE COMPANY’S
OBLIGATIONS TO SELL

 

The obligation
of the Company hereunder to issue and sell the Securities to the Buyer at the Closings is subject to the satisfaction, at or before
the respective Closing Dates, of each of the following conditions, provided that these conditions are for the Company’s sole
benefit and may be waived by the Company at any time in its sole discretion:

 

8.1Buyer
shall have executed the Transaction Documents and delivered them to the Company.

 

8.2The
representations and warranties of the Buyer shall be true and correct in all material respects as of the date when made and as
of the Closing Dates as though made at that time (except for representations and warranties that speak as of a specific date),
and the Buyer shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions
required by this Agreement to be performed, satisfied or complied with by the Buyer at or prior to the Closing Dates.

 

8.3The
Company shall have received such certificates, confirmations, resolutions, acknowledgements or other documentation necessary or
advisable from all applicable Governmental Authorities, including, but not limited to, those located in the State of Nevada, as
the Company may require in order to evidence such Governmental Authorities’ approval of this Agreement, the Transaction Documents
and the purchase of the Debentures contemplated hereby.

 

    	33

     

    

 

ARTICLE IX

CONDITIONS PRECEDENT TO THE BUYER’S
OBLIGATIONS TO PURCHASE

 

The obligation
of the Buyer hereunder to purchase the Debentures at the Closings is subject to the satisfaction, at or before each applicable
Closing Date, of each of the following conditions (in addition to any other conditions precedent elsewhere in this Agreement),
provided that these conditions are for the Buyer’s sole benefit and may be waived by the Buyer at any time in its sole discretion:

 

9.1First
Closing. The obligation of the Buyer hereunder to purchase the Debentures at the First Closing is subject to the satisfaction,
at or before the First Closing Date, of each of the following conditions (in addition to any other conditions precedent elsewhere
in this Agreement), provided that these conditions are for the Buyer’s sole benefit and may be waived by the Buyer at any
time in its sole discretion:

 

(a)The
Company, each Guarantor and/or the Chief Executive Officer (as applicable) shall have executed and delivered the Transaction Documents
applicable to the First Closing and delivered the same to the Buyer.

 

(b)The
representations and warranties of the Company shall be true and correct in all material respects (except to the extent that any
of such representations and warranties are already qualified as to materiality in Article VI above, in which case, such representations
and warranties shall be true and correct in all respects without further qualification) as of the date when made and as of the
First Closing Date as though made at that time (except for representations and warranties that speak as of a specific date) and
the Company and each Guarantor shall have performed, satisfied and complied in all material respects with the covenants, agreements
and conditions required by this Agreement to be performed, satisfied or complied with by the Company and each Guarantor at or prior
to the First Closing Date.

 

(c)The
Buyer shall have received an opinion of counsel from counsel to the Company in a form satisfactory to the Buyer and its counsel.

 

(d)The
Buyer shall have received evidence in a form satisfactory to the Buyer that the Company has authorized the Buyer to publish such
press releases with respect to this Agreement and the instant transaction, including, but not limited to, a copy of an email delivered
to Marketwire.com by the Company whereby the Company authorizes the Buyer to use its name and, if applicable, stock symbol, in
connection with current or future press releases.

 

    	34

     

    

 

(e)The
Company and each Guarantor shall have executed and delivered to Buyer a closing certificate, certified as true, complete and correct
by an officer of the Company or Guarantor, in substance and form required by Buyer, which closing certificate shall include and
attach as exhibits: (i) a true copy of a certificate of good standing evidencing the formation and good standing of the Company
or Guarantor from the secretary of state (or comparable office) from the jurisdiction in which the Company is formed; (ii) the
Company’s or Guarantor’s Organizational Documents; (iii) copies of the resolutions of the board of directors of the
Company or Guarantor as adopted by the Company’s or Guarantor’s board of directors, in a form acceptable to Buyer;
and (iv) resolution of the Guarantor’s shareholders, approving and authorizing the execution, delivery and performance of
the Transaction Documents to which it is party and the transactions contemplated thereby, in a form acceptable to the Buyer.

 

(f) No event
shall have occurred which could reasonably be expected to have a Material Adverse Effect.

 

(g) The Buyer
shall have received copies of UCC search reports, issued by the Secretary of State of the state of incorporation or residency,
as applicable, of the Company and each Guarantor, dated such a date as is reasonably acceptable to Buyer, listing all effective
financing statements which name the Company and each Guarantor, under their present name and any previous names, as debtors, together
with copies of such financing statements.

 

(h) The Company
and each Guarantor shall have executed such other agreements, certificates, confirmations or resolutions as the Buyer may reasonably
require to consummate the transactions contemplated by this Agreement and the Transaction Documents, including a closing statement
and joint disbursement instructions as may be reasonably required by Buyer.

 

9.2Additional
Closing. Provided the Buyer is to purchase additional Debentures in accordance with Section 4.4 at an Additional Closing,
the obligation of the Buyer hereunder to accept and purchase the Debentures at any Additional Closing is subject to the satisfaction,
at or before the Additional Closing Date, of each of the following conditions:

 

(a)The
Company and each Guarantor shall have executed the Transaction Documents applicable to the Additional Closing and delivered the
same to the Buyer.

 

(b)The
representations and warranties of the Company shall be true and correct in all material respects (except to the extent that any
of such representations and warranties are already qualified as to materiality in Article VI above, in which case, such representations
and warranties shall be true and correct in all respects without further qualification) as of the date when made and as of the
Additional Closing Date as though made at that time (except for representations and warranties that speak as of a specific date)
and the Company shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions
required by this Agreement to be performed, satisfied or complied with by the Company at or prior to the Additional Closing Date.

 

(c)No
event shall have occurred which could reasonably be expected to have a Material Adverse Effect.

 

    	35

     

    

 

(d)No
default or Event of Default shall have occurred and be continuing under this Agreement or any other Transaction Documents, and
no event shall have occurred that, with the passage of time, the giving of notice, or both, would constitute a default or an Event
of Default under this Agreement or any other Transaction Documents.

 

(e)The
Company and each Guarantor shall have executed such other agreements, certificates, confirmations or resolutions as the Buyer may
reasonably require to consummate the transactions contemplated by this Agreement and the Transaction Documents, including a closing
statement and joint disbursement instructions as may be reasonably required by Buyer.

 

ARTICLE X

INDEMNIFICATION

 

10.1Company’s
and the Guarantors’ Obligation to Indemnify. In consideration of the Buyer’s execution and delivery of this Agreement
and acquiring the Securities hereunder, and in addition to all of the Company’s and the Guarantors’ other obligations
under this Agreement, the Company and each Guarantor hereby agrees to defend and indemnify Buyer and its Affiliates and subsidiaries
and their respective directors, officers, employees, agents and representatives, and the successors and assigns of each of them
(collectively, the “Buyer Indemnified Parties”) and Company and each Guarantor does hereby agree to hold
the Buyer Indemnified Parties forever harmless, from and against any and all Claims made, brought or asserted against the Buyer
Indemnified Parties, or any one of them, and Company and each Guarantor hereby agrees to pay or reimburse the Buyer Indemnified
Parties for any and all Claims payable by any of the Buyer Indemnified Parties to any Person, including reasonable attorneys’
and paralegals’ fees and expenses, court costs, settlement amounts, costs of investigation and interest thereon from the
time such amounts are due at the rate applicable to Debentures, through all negotiations, mediations, arbitrations, trial and appellate
levels, as a result of, or arising out of, or relating to: (i) any misrepresentation or breach of any representation or warranty
made by the Company and the Guarantors in this Agreement, the Transaction Documents or any other certificate, instrument or document
contemplated hereby or thereby; (ii) any breach of any covenant, agreement or Obligation of the Company and the Guarantors contained
in this Agreement, the Transaction Documents or any other certificate, instrument or document contemplated hereby or thereby; or
(iii) any Claims brought or made against the Buyer Indemnified Parties, or any one of them, by a third party and arising out of
or resulting from the execution, delivery, performance or enforcement of this Agreement, the Transaction Documents or any other
instrument, document or agreement executed pursuant hereto or thereto, any transaction financed or to be financed in whole or in
part, directly or indirectly, with the proceeds of the issuance of the Debentures, or the status of the Buyer or holder of any
of the Securities, as a buyer and holder of such Securities in the Company. To the extent that the foregoing undertaking by the
Company and the Guarantors may be unenforceable for any reason, the Company and the Guarantors shall make the maximum contribution
to the payment and satisfaction of each of the Claims covered hereby, which is permissible under applicable Law. Notwithstanding
anything to the contrary in the foregoing, this Section shall not apply to acts of gross negligence or willful misconduct by the
Buyer Indemnified Parties.

    	36

     

    

 

 

ARTICLE XI

MISCELLANEOUS

 

11.1Notices.
All notices of request, demand and other communications hereunder shall be addressed to the parties as follows:

 

	If to the Company:	Medytox Solutions, Inc.
	 	400 South Australian Avenue, 8th Floor
	 	West Palm Beach, FL 33401
	 	Attention:  Jace Simmons 
	 	E-Mail: jsimmons@medytoxsolutionsinc.com
	 	 
	With a copy to:	Akerman LLP 
	(which shall not constitute notice)	One Southeast Third Avenue 
	 	Miami, FL 33131 
	 	Attention:  Dean M. Freitag, Esq. 
	 	E-Mail: dean.freitag@akerman.com 
	 	 
	If to the Buyer:	TCA Global Credit Master Fund, LP 
	  	3960 Howard Hughes Parkway, Suite 500
	 	Las Vegas, NV 89169
	 	Attn: Mr. Robert Press
	 	E-Mail:  bpress@tcaglobalfund.com
	 	 
	With a copy to:	Lucosky Brookman LLP
	(which shall not constitute notice)	101 Wood Avenue South, 5th Floor 
	 	Woodbridge, NJ 08830
	 	Attn: Seth A. Brookman, Esq. 
	 	E-Mail:  sbrookman@lucbro.com

 

unless the address
is changed by the party by like notice given to the other parties. Notice shall be in writing and shall be deemed delivered: (i)
if mailed by certified mail, return receipt requested, postage prepaid and properly addressed to the address below, then three
(3) business days after deposit of same in a regularly maintained U.S. Mail receptacle; or (ii) if mailed by Federal Express, UPS
or other nationally recognized overnight courier service, next business morning delivery, then one (1) business day after deposit
of same in a regularly maintained receptacle of such overnight courier; or (iii) if hand delivered, then upon hand delivery thereof
to the address indicated on or prior to 5:00 p.m., EST, on a business day. Any notice hand delivered after 5:00 p.m., EST, shall
be deemed delivered on the following business day. Notwithstanding the foregoing, notice, consents, waivers or other communications
referred to in this Agreement may be sent by facsimile, e-mail, or other method of delivery, but shall be deemed to have been delivered
only when the sending party has confirmed (by reply e-mail or some other form of written confirmation from the receiving party)
that the notice has been received by the other party.

 

    	37

     

    

 

11.2Obligations
Absolute. None of the following shall affect the Obligations of the Company and the Guarantors to Buyer under this Agreement,
Buyer’s rights with respect to the Collateral or any other Transaction Documents:

 

(a)acceptance
or retention by Buyer of other property or any interest in property as security for the Obligations;

 

(b)release
by Buyer of all or any part of the Collateral or of any party liable with respect to the Obligations (other than Company and the
Guarantors);

 

(c)release,
extension, renewal, modification or substitution by Buyer of the debentures or any other Transaction Documents; or

 

(d)failure
of Buyer to resort to any other security or to pursue the Company or any other obligor liable for any of the Obligations of the
Company and the Guarantors hereunder before resorting to remedies against the Collateral.

 

11.3Entire
Agreement. This Agreement and the other Transaction Documents: (i) are valid, binding and enforceable against the Company,
the Guarantors and Buyer in accordance with its provisions and no conditions exist as to their legal effectiveness; (ii) constitute
the entire agreement between the parties; and (iii) are the final expression of the intentions of the Company, the Guarantors and
Buyer. No promises, either expressed or implied, exist between the Company, the Guarantors and Buyer, unless contained herein or
in the Transaction Documents. This Agreement and the Transaction Documents supersede all negotiations, representations, warranties,
commitments, offers, contracts (of any kind or nature, whether oral or written) prior to or contemporaneous with the execution
hereof.

 

11.4Amendments;
Waivers. No amendment, modification, termination, discharge or waiver of any provision of this Agreement or of the Transaction
Documents, or consent to any departure by the Company or the Guarantors therefrom, shall in any event be effective unless the same
shall be in writing and signed by Buyer, and then such waiver or consent shall be effective only for the specific purpose for which
given.

 

11.5WAIVER
OF JURY TRIAL. BUYER, THE COMPANY AND THE GUARANTORS, AFTER CONSULTING OR HAVING HAD THE OPPORTUNITY TO CONSULT WITH COUNSEL,
EACH KNOWINGLY, VOLUNTARILY AND INTENTIONALLY WAIVES, IRREVOCABLY, THE RIGHT TO TRIAL BY JURY WITH RESPECT TO ANY LEGAL PROCEEDING
BASED HEREON, OR ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT, ANY TRANSACTION DOCUMENT OR ANY OF THE OBLIGATIONS
HEREUNDER, THE COLLATERAL, OR ANY OTHER AGREEMENT EXECUTED OR CONTEMPLATED TO BE EXECUTED IN CONJUNCTION WITH THIS AGREEMENT, OR
ANY COURSE OF CONDUCT OR COURSE OF DEALING IN WHICH BUYER AND THE COMPANY AND/OR THE GUARANTORS ARE ADVERSE PARTIES. THIS PROVISION
IS A MATERIAL INDUCEMENT FOR BUYER PURCHASING THE DEBENTURES.

 

    	38

     

    

 

11.6MANDATORY
FORUM SELECTION. TO INDUCE BUYER TO PURCHASE THE DEBENTURES, THE COMPANY AND GUARANTORS IRREVOCABLY AGREE THAT ANY DISPUTE
ARISING UNDER, RELATING TO, OR IN CONNECTION WITH, DIRECTLY OR INDIRECTLY, THIS AGREEMENT OR RELATED TO ANY MATTER WHICH IS THE
SUBJECT OF OR INCIDENTAL TO THIS AGREEMENT ANY OTHER TRANSACTION DOCUMENT (WHETHER OR NOT SUCH CLAIM IS BASED UPON BREACH OF CONTRACT
OR TORT) SHALL BE SUBJECT TO THE EXCLUSIVE JURISDICTION AND VENUE OF THE STATE AND/OR FEDERAL COURTS LOCATED IN BROWARD COUNTY,
FLORIDA. THIS PROVISION IS INTENDED TO BE A “MANDATORY” FORUM SELECTION CLAUSE AND GOVERNED BY AND INTERPRETED CONSISTENT
WITH FLORIDA LAW. THE COMPANY AND EACH GUARANTOR HEREBY CONSENT TO THE EXCLUSIVE JURISDICTION AND VENUE OF ANY STATE OR FEDERAL
COURT HAVING ITS SITUS IN SAID COUNTY, AND WAIVES ANY OBJECTION BASED ON FORUM NON CONVENIENS. THE COMPANY AND EACH GUARANTOR HEREBY
WAIVE PERSONAL SERVICE OF ANY AND ALL PROCESS AND CONSENT THAT ALL SUCH SERVICE OF PROCESS MAY BE MADE BY CERTIFIED MAIL, RETURN
RECEIPT REQUESTED, DIRECTED TO THE COMPANY AND GUARANTORS AS SET FORTH HEREIN IN THE MANNER PROVIDED BY APPLICABLE STATUTE, LAW,
RULE OF COURT OR OTHERWISE.

 

11.7Assignability.
Buyer may at any time assign Buyer’s rights in this Agreement, the Debentures, any Transaction Document, or any part thereof
and transfer Buyer’s rights in any or all of the Collateral, and Buyer thereafter shall be relieved from all liability with
respect to such Collateral. In addition, Buyer may at any time sell one or more participations in the Debentures. Except for in
connection with the Merger, the Company and the Guarantors may not sell or assign this Agreement, any Transaction Document or any
other agreement with Buyer, or any portion thereof, either voluntarily or by operation of law, nor delegate any of its duties of
obligations hereunder or thereunder, without the prior written consent of Buyer, which consent may be withheld or conditioned in
Buyer’s sole and absolute discretion. This Agreement shall be binding upon Buyer, the Guarantors and the Company and their
respective legal representatives, successors and permitted assigns. All references herein to a Company or the Guarantor shall be
deemed to include any successors, whether immediate or remote. In the case of a joint venture or partnership, the term “Company”,
or “Guarantor” shall be deemed to include all joint venturers or partners thereof, who shall be jointly and severally
liable hereunder.

 

11.8Publicity.
Buyer shall have the right to approve, before issuance, any press release or any other public statement with respect to the transactions
contemplated hereby made by the Company; provided, however, that the Company shall be entitled, without the prior approval of Buyer,
to issue any press release or other public disclosure with respect to such transactions required under applicable securities or
other laws or regulations. Notwithstanding the foregoing, the Company shall use its best efforts to consult Buyer in connection
with any such press release or other public disclosure prior to its release and Buyer shall be provided with a copy thereof upon
release thereof. Buyer shall have the right to make any press release with respect to the transactions contemplated hereby without
Company’s approval. In addition, with respect to any press release to be made by Buyer, the Company hereby authorizes and
grants blanket permission to Buyer to include the Company’s stock symbol, if any, in any press releases. The Company shall,
promptly upon request, execute any additional documents of authority or permission as may be reasonably requested by Buyer in connection
with any such press releases.

 

    	39

     

    

 

11.9Binding
Effect. This Agreement shall become effective upon execution by the Company, the Guarantors and Buyer.

 

11.10Governing
Law. Except in the case of the Mandatory Forum Selection Clause in Section 11.6 above, which clause shall be governed
and interpreted in accordance with Florida law, this Agreement and all other Transaction Documents shall be delivered and accepted
in and shall be deemed to be contracts made under and governed by the internal laws of the State of Nevada, and for all purposes
shall be construed in accordance with the laws of such State, without giving effect to the choice of law provisions of such State.

 

11.11Enforceability.
Wherever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of this Agreement shall be prohibited by, unenforceable or invalid under any jurisdiction, such provision
shall as to such jurisdiction, be severable and be ineffective to the extent of such prohibition or invalidity, without invalidating
the remaining provisions of this Agreement or affecting the validity or enforceability of such provision in any other jurisdiction.

 

11.12Survival
of Company’s and the Guarantors’ Representations. All covenants, agreements, representations and warranties made
by the Company and the Guarantors herein shall, notwithstanding any investigation by Buyer, be deemed material and relied upon
by Buyer and shall survive the making and execution of this Agreement and the Transaction Documents and the sale and purchase of
the Debentures, and shall be deemed to be continuing representations and warranties until such time as the Company and the Guarantors
have fulfilled all of its Obligations to Buyer hereunder and under all other Transaction Documents, and Buyer has been indefeasibly
paid in full.

 

11.13Time
of Essence. Time is of the essence in making payments of all amounts due Buyer under this Agreement and the other Transaction
Documents and in the performance and observance by the Company and the Guarantors of each covenant, agreement, provision and term
of this Agreement and the other Transaction Documents. The parties agree that in the event that any date on which performance is
to occur falls on a day other than a Business Day, then the time for such performance shall be extended until the next Business
Day thereafter occurring.

 

11.14Release.
In consideration of the mutual promises and covenants made herein, and other good and valuable consideration, the receipt and sufficiency
of which is hereby acknowledged, and intending to be legally bound hereby, the Company and the Guarantors hereby agree to fully,
finally and forever release and forever discharge and covenant not to sue Buyer, and/or any other Buyer Indemnified Parties from
any and all Claims, debts, fees, attorneys’ fees, liens, costs, expenses, damages, sums of money, accounts, bonds, bills,
covenants, promises, judgments, charges, demands, causes of action, suits, Proceedings, liabilities, expenses, Obligations or Contracts
of any kind whatsoever, whether in law or in equity, whether asserted or unasserted, whether known or unknown, fixed or contingent,
under statute or otherwise, from the beginning of time through the Effective Date, including, without limiting the generality of
the foregoing, any and all Claims relating to or arising out of any financing transactions, credit facilities, debentures, security
agreements, and other agreements including each of the Transaction Documents, entered into by the Company and the Guarantors with
Buyer and any and all Claims that the Company and the Guarantors do not know or suspect to exist, whether through ignorance, oversight,
error, negligence, or otherwise, and which, if known, would materially affect their decision to enter into this Agreement or the
related Transaction Documents.

 

    	40

     

    

 

11.15Interpretation.
If any provision in this Agreement requires judicial or similar interpretation, the judicial or other such body interpreting or
construing such provision shall not apply the assumption that the terms hereof shall be more strictly construed against one party
because of the rule that an instrument must be construed more strictly against the party which itself or through its agents prepared
the same. The parties hereby agree that all parties and their agents have participated in the preparation hereof equally.

 

11.16Compliance
with Federal Law. The Company shall: (i) ensure that no Person who owns a controlling interest in or otherwise controls the
Company is or shall be listed on the Specially Designated Nationals and Blocked Person List or other similar lists maintained by
the Office of Foreign Assets Control (“OFAC”), the Department of the Treasury, included in any Executive Orders
or any other similar lists from any Governmental Authority, foreign or national; (ii) not use or permit the use of the proceeds
of the Debentures to violate any of the foreign asset control regulations of OFAC or any enabling statute or Executive Order relating
thereto, or any other similar national or foreign governmental regulations; and (iii) comply with all applicable Lender Secrecy
Act laws and regulations, as amended. As required by federal law and Buyer’s policies and practices, Buyer may need to obtain,
verify and record certain customer identification information and documentation in connection with opening or maintaining accounts
or establishing or continuing to provide services.

 

11.17Termination.
Upon payment in full of all outstanding Debentures purchased hereunder, together with all other charges, fees and costs due and
payable under this Agreement or under any of the Transaction Documents, the Company shall have the right to terminate this Agreement
upon written notice to the Buyer, provided, however, that if such termination occurs within twelve (12) months after the First
Closing Date, then the Company shall pay to Buyer as liquidated damages and compensation for the costs of being prepared to make
funds available hereunder, an amount equal to five percent (5%) of the then outstanding principal amount of Debentures purchased
hereunder. The parties agree that the amount payable to pursuant to this Section 11.17 is a reasonable calculation of Buyer’s
lost profits in view of the difficulties and impracticality of determining actual damages resulting from an early termination of
this Agreement.

 

    	41

     

    

 

11.18Gender
and Use of Singular and Plural. All pronouns shall be deemed to refer to the masculine, feminine, neuter, singular or plural,
as the identity of the party or parties or their personal representatives, successors and assigns may require.

 

11.19Execution.
This Agreement may be executed in one or more counterparts, all of which taken together shall be deemed and considered one and
the same Agreement, and same shall become effective when counterparts have been signed by each party and each party has delivered
its signed counterpart to the other party. In the event that any signature is delivered by facsimile transmission or by e-mail
delivery of a “.pdf’ format file or other similar format file, such signature shall be deemed an original for all purposes
and shall create a valid and binding obligation of the party executing same with the same force and effect as if such facsimile
or “.pdf’ signature page was an original thereof.

 

11.20Headings.
The article and section headings contained in this Agreement are inserted for convenience only and shall not affect in any way
the meaning or interpretation of the Agreement.

 

11.21Further
Assurances. The Company and the Guarantors will execute and deliver such further instruments and do such further acts and things
as may be reasonably required by Buyer to carry out the intent and purposes of this Agreement.

 

11.22No
Third Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective permitted
successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person.

 

 

[signature pages follow]

 

    	42

     

    

 

IN WITNESS WHEREOF, the parties hereto have
caused this Agreement to be executed as of the date and year set forth above.

 

COMPANY:

 

MEDYTOX SOLUTIONS, INC.

 

 

 

By: /s/ Seamus Lagan

Name: Seamus Lagan

Title: Chief Executive Officer

 

	STATE OF ________________	)
	 	) SS.
	COUNTY OF ______________	)

 

The undersigned, a Notary
Public in and for the said County, in the State aforesaid, DO HEREBY CERTIFY that Seamus Lagan, the Chief Executive Officer of
Medytox Solutions, Inc., a Nevada corporation, who is personally known to me to be the same person whose name is subscribed to
the foregoing instrument, appeared before me this day in person and acknowledged that he/she signed and delivered the said instrument
as his/her own free and voluntary act and as the free and voluntary act of said corporation, for the uses and purposes therein
set forth.

 

GIVEN under my hand and notarial seal this _____
day of ________________, 20____.

 

 

	 	 
	 	Notary Public
	 	 
	 	My Commission Expires:
	 	 
	 	 

 

 

 

    	43

     

    

 

BUYER:

 

TCA GLOBAL CREDIT MASTER FUND, LP

 

By: TCA Global Credit Master Fund GP, Ltd.

Its: General Partner

 

 

By:  /s/ Robert Press

Name: Robert Press

Title:Managing Director

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	44

     

    

 

 

CONSENT AND AGREEMENT

 

The undersigned, referred to in the foregoing
securities purchase agreement as a guarantor, hereby consents and agrees to said securities purchase agreement and to the payment
of the amounts contemplated therein, documents contemplated thereby and to the provisions contained therein relating to conditions
to be fulfilled and obligations to be performed by it pursuant to or in connection with said securities purchase agreement to the
same extent as if the undersigned were a party to said securities purchase agreement.

 

GUARANTOR:

 

MEDYTOX INFORMATION TECHNOLOGY, INC.

 

 

By:/s/ Seamus Lagan

Name: Seamus Lagan

Title:Chief Executive Officer

 

	STATE OF ________________	)
	 	) SS.
	COUNTY OF ______________	)

 

 

The undersigned, a Notary
Public in and for the said County, in the State aforesaid, DO HEREBY CERTIFY that Seamus Lagan, the Chief Executive Officer of
Medytox Information Technology, Inc., a Florida corporation, who is personally known to me to be the same person whose name is
subscribed to the foregoing instrument, appeared before me this day in person and acknowledged that he/she signed and delivered
the said instrument as his/her own free and voluntary act and as the free and voluntary act of said corporation, for the uses and
purposes therein set forth.

 

GIVEN under my hand and
notarial seal this _____ day of ________________, 20____.

 

 

	 	 
	 	Notary Public
	 	 
	 	My Commission Expires:
	 	 
	 	 

 

 

 

    	45

     

    

CONSENT AND AGREEMENT

 

The undersigned, referred to in the foregoing
securities purchase agreement as a guarantor, hereby consents and agrees to said securities purchase agreement and to the payment
of the amounts contemplated therein, documents contemplated thereby and to the provisions contained therein relating to conditions
to be fulfilled and obligations to be performed by it pursuant to or in connection with said securities purchase agreement to the
same extent as if the undersigned were a party to said securities purchase agreement.

 

GUARANTOR:

 

MEDYTOX INSTITUTE OF LABORATORY MEDICINE, INC.

 

 

By:/s/ Seamus Lagan

Name: Seamus Lagan

Title:Chief Executive Officer

 

	STATE OF ________________	)
	 	) SS.
	COUNTY OF ______________	)

 

 

The undersigned, a Notary
Public in and for the said County, in the State aforesaid, DO HEREBY CERTIFY that Seamus Lagan, the Chief Executive Officer of
Medytox Institute of Laboratory Medicine, Inc., a Florida corporation, who is personally known to me to be the same person whose
name is subscribed to the foregoing instrument, appeared before me this day in person and acknowledged that he/she signed and delivered
the said instrument as his/her own free and voluntary act and as the free and voluntary act of said corporation, for the uses and
purposes therein set forth.

 

GIVEN under my hand and notarial seal this _____
day of ________________, 20____.

 

 

	 	 
	 	Notary Public
	 	 
	 	My Commission Expires:
	 	 
	 	 

 

 

 

    	46

     

    

 

CONSENT AND AGREEMENT

 

The undersigned, referred to in the foregoing
securities purchase agreement as a guarantor, hereby consents and agrees to said securities purchase agreement and to the payment
of the amounts contemplated therein, documents contemplated thereby and to the provisions contained therein relating to conditions
to be fulfilled and obligations to be performed by it pursuant to or in connection with said securities purchase agreement to the
same extent as if the undersigned were a party to said securities purchase agreement.

 

GUARANTOR:

 

MEDICAL BILLING CHOICES, INC.

 

 

By:/s/ Seamus Lagan

Name: Seamus Lagan

Title:President

 

	STATE OF ________________	)
	 	) SS.
	COUNTY OF ______________	)

 

 

The undersigned, a Notary
Public in and for the said County, in the State aforesaid, DO HEREBY CERTIFY that Seamus Lagan, the President of Medical Billing
Choices Inc., a North Carolina corporation, who is personally known to me to be the same person whose name is subscribed to the
foregoing instrument, appeared before me this day in person and acknowledged that he/she signed and delivered the said instrument
as his/her own free and voluntary act and as the free and voluntary act of said corporation, for the uses and purposes therein
set forth.

 

GIVEN under my hand and
notarial seal this _____ day of ________________, 20____.

 

	 	 
	 	Notary Public
	 	 
	 	My Commission Expires:
	 	 
	 	 

 

    	47

     

    

 

CONSENT AND AGREEMENT

 

The undersigned, referred to in the foregoing
securities purchase agreement as a guarantor, hereby consents and agrees to said securities purchase agreement and to the payment
of the amounts contemplated therein, documents contemplated thereby and to the provisions contained therein relating to conditions
to be fulfilled and obligations to be performed by it pursuant to or in connection with said securities purchase agreement to the
same extent as if the undersigned were a party to said securities purchase agreement.

 

GUARANTOR:

 

MEDYTOX DIAGNOSTICS, INC.

 

 

By:/s/ Seamus Lagan

Name: Seamus Lagan

Title:Chief Executive Officer

 

	STATE OF ________________	)
	 	) SS.
	COUNTY OF ______________	)

 

 

The undersigned, a Notary
Public in and for the said County, in the State aforesaid, DO HEREBY CERTIFY that Seamus Lagan, the Chief Executive Officer of
Medytox Diagnostics, Inc., a Florida corporation, who is personally known to me to be the same person whose name is subscribed
to the foregoing instrument, appeared before me this day in person and acknowledged that he/she signed and delivered the said instrument
as his/her own free and voluntary act and as the free and voluntary act of said corporation, for the uses and purposes therein
set forth.

 

GIVEN under my hand and
notarial seal this _____ day of ________________, 20____.

 

	 	 
	 	Notary Public
	 	 
	 	My Commission Expires:
	 	 
	 	 

 

    	48

     

    

 

CONSENT AND AGREEMENT

 

The undersigned, referred to in the foregoing
securities purchase agreement as a guarantor, hereby consents and agrees to said securities purchase agreement and to the payment
of the amounts contemplated therein, documents contemplated thereby and to the provisions contained therein relating to conditions
to be fulfilled and obligations to be performed by it pursuant to or in connection with said securities purchase agreement to the
same extent as if the undersigned were a party to said securities purchase agreement.

 

GUARANTOR:

 

MEDYTOX MEDICAL MARKETING & SALES, INC.

 

 

By:/s/ Seamus Lagan

Name: Seamus Lagan

Title:Chief Executive Officer

 

	STATE OF ________________	)
	 	) SS.
	COUNTY OF ______________	)

 

 

The undersigned, a Notary
Public in and for the said County, in the State aforesaid, DO HEREBY CERTIFY that Seamus Lagan, the Chief Executive Officer of
Medytox Medical Marketing & Sales, Inc., a Florida corporation, who is personally known to me to be the same person whose name
is subscribed to the foregoing instrument, appeared before me this day in person and acknowledged that he/she signed and delivered
the said instrument as his/her own free and voluntary act and as the free and voluntary act of said corporation, for the uses and
purposes therein set forth.

 

GIVEN under my hand and notarial seal this _____
day of ________________, 20____.

 

	 	 
	 	Notary Public
	 	 
	 	My Commission Expires:
	 	 
	 	 

 

    	49

     

    

 

CONSENT AND AGREEMENT

 

The undersigned, referred to in the foregoing
securities purchase agreement as a guarantor, hereby consents and agrees to said securities purchase agreement and to the payment
of the amounts contemplated therein, documents contemplated thereby and to the provisions contained therein relating to conditions
to be fulfilled and obligations to be performed by it pursuant to or in connection with said securities purchase agreement to the
same extent as if the undersigned were a party to said securities purchase agreement.

 

GUARANTOR:

 

PB LABORATORIES, LLC

 

 

By:/s/ Norma Villar

Name: Norma Villar

Title:Chief Financial Officer

 

	STATE OF ________________	)
	 	) SS.
	COUNTY OF ______________	)

 

 

 

The undersigned, a Notary
Public in and for the said County, in the State aforesaid, DO HEREBY CERTIFY that Norma Villar, the Chief Financial Officer of
PB Laboratories, LLC, a Florida limited liability company, who is personally known to me to be the same person whose name is subscribed
to the foregoing instrument, appeared before me this day in person and acknowledged that he/she signed and delivered the said instrument
as his/her own free and voluntary act and as the free and voluntary act of said corporation, for the uses and purposes therein
set forth.

 

GIVEN under my hand and notarial seal this _____
day of ________________, 20____.

 

	 	 
	 	Notary Public
	 	 
	 	My Commission Expires:
	 	 
	 	 

 

    	50

     

    

 

CONSENT AND AGREEMENT

 

The undersigned, referred to in the foregoing
securities purchase agreement as a guarantor, hereby consents and agrees to said securities purchase agreement and to the payment
of the amounts contemplated therein, documents contemplated thereby and to the provisions contained therein relating to conditions
to be fulfilled and obligations to be performed by it pursuant to or in connection with said securities purchase agreement to the
same extent as if the undersigned were a party to said securities purchase agreement.

 

GUARANTOR:

 

BIOHEALTH MEDICAL LABORATORY, INC.

 

 

By:/s/ Norma Villar

Name: Norma Villar

Title:Chief Financial Officer

 

	STATE OF ________________	)
	 	) SS.
	COUNTY OF ______________	)

 

 

 

The undersigned, a Notary
Public in and for the said County, in the State aforesaid, DO HEREBY CERTIFY that Norma Villar, the Chief Financial Officer of
Biohealth Medical Laboratory Inc., a Florida corporation, who is personally known to me to be the same person whose name is subscribed
to the foregoing instrument, appeared before me this day in person and acknowledged that he/she signed and delivered the said instrument
as his/her own free and voluntary act and as the free and voluntary act of said corporation, for the uses and purposes therein
set forth.

 

GIVEN under my hand and notarial seal this _____
day of ________________, 20____.

 

	 	 
	 	Notary Public
	 	 
	 	My Commission Expires:
	 	 
	 	 

 

 

    	51

     

    

 

CONSENT AND AGREEMENT

 

The undersigned, referred to in the foregoing
securities purchase agreement as a guarantor, hereby consents and agrees to said securities purchase agreement and to the payment
of the amounts contemplated therein, documents contemplated thereby and to the provisions contained therein relating to conditions
to be fulfilled and obligations to be performed by it pursuant to or in connection with said securities purchase agreement to the
same extent as if the undersigned were a party to said securities purchase agreement.

 

GUARANTOR:

 

ALETHEA LABORATORIES, INC.

 

 

By:/s/ Norma Villar

Name: Norma Villar

Title:Chief Financial Officer

 

	STATE OF ________________	)
	 	) SS.
	COUNTY OF ______________	)

 

 

The undersigned, a Notary
Public in and for the said County, in the State aforesaid, DO HEREBY CERTIFY that Norma Villar, the Chief Financial Officer of
Alethea Laboratories, Inc., a Texas corporation, who is personally known to me to be the same person whose name is subscribed to
the foregoing instrument, appeared before me this day in person and acknowledged that he/she signed and delivered the said instrument
as his/her own free and voluntary act and as the free and voluntary act of said corporation, for the uses and purposes therein
set forth.

 

GIVEN under my hand and notarial seal this _____
day of ________________, 20____.

 

	 	 
	 	Notary Public
	 	 
	 	My Commission Expires:
	 	 
	 	 

 

 

    	52

     

    

 

CONSENT AND AGREEMENT

 

The undersigned, referred to in the foregoing
securities purchase agreement as a guarantor, hereby consents and agrees to said securities purchase agreement and to the payment
of the amounts contemplated therein, documents contemplated thereby and to the provisions contained therein relating to conditions
to be fulfilled and obligations to be performed by it pursuant to or in connection with said securities purchase agreement to the
same extent as if the undersigned were a party to said securities purchase agreement.

 

GUARANTOR:

 

INTERNATIONAL TECHNOLOGIES, LLC

 

 

By:/s/ Dr. William DePond

Name: Dr. William DePond

Title:Manager

 

	STATE OF ________________	)
	 	) SS.
	COUNTY OF ______________	)

 

 

The undersigned, a Notary
Public in and for the said County, in the State aforesaid, DO HEREBY CERTIFY that Dr. William DePond, the Manager of International
Technologies, LLC, a New Jersey limited liability company, who is personally known to me to be the same person whose name is subscribed
to the foregoing instrument, appeared before me this day in person and acknowledged that he/she signed and delivered the said instrument
as his/her own free and voluntary act and as the free and voluntary act of said corporation, for the uses and purposes therein
set forth.

 

GIVEN under my hand and notarial seal this _____
day of ________________, 20____.

 

	 	 
	 	Notary Public
	 	 
	 	My Commission Expires:
	 	 
	 	 

 

 

    	53

     

    

 

CONSENT AND AGREEMENT

 

The undersigned, referred to in the foregoing
securities purchase agreement as a guarantor, hereby consents and agrees to said securities purchase agreement and to the payment
of the amounts contemplated therein, documents contemplated thereby and to the provisions contained therein relating to conditions
to be fulfilled and obligations to be performed by it pursuant to or in connection with said securities purchase agreement to the
same extent as if the undersigned were a party to said securities purchase agreement.

 

GUARANTOR:

 

EPIC REFERENCE LABS, INC.

 

 

By:/s/ Norma Villar

Name: Norma Villar

Title:Chief Financial Officer

 

	STATE OF ________________	)
	 	) SS.
	COUNTY OF ______________	)

 

The undersigned, a Notary
Public in and for the said County, in the State aforesaid, DO HEREBY CERTIFY that Norma Villar, the Chief Financial Officer of
EPIC Reference Labs, Inc., a Florida corporation, who is personally known to me to be the same person whose name is subscribed
to the foregoing instrument, appeared before me this day in person and acknowledged that he/she signed and delivered the said instrument
as his/her own free and voluntary act and as the free and voluntary act of said corporation, for the uses and purposes therein
set forth.

 

GIVEN under my hand and notarial seal this _____
day of ________________, 20____.

 

 

	 	 
	 	Notary Public
	 	 
	 	My Commission Expires:
	 	 
	 	 

 

 

    	54

     

    

 

CONSENT AND AGREEMENT

 

The undersigned, referred to in the foregoing
securities purchase agreement as a guarantor, hereby consents and agrees to said securities purchase agreement and to the payment
of the amounts contemplated therein, documents contemplated thereby and to the provisions contained therein relating to conditions
to be fulfilled and obligations to be performed by it pursuant to or in connection with said securities purchase agreement to the
same extent as if the undersigned were a party to said securities purchase agreement.

 

GUARANTOR:

 

CLINLAB, INC.

 

 

By:/s/ Seamus Lagan

Name: Seamus Lagan

Title:President

 

	STATE OF ________________	)
	 	) SS.
	COUNTY OF ______________	)

 

 

The undersigned, a Notary
Public in and for the said County, in the State aforesaid, DO HEREBY CERTIFY that Seamus Lagan, the President of Clinlab, Inc.,
a Florida corporation, who is personally known to me to be the same person whose name is subscribed to the foregoing instrument,
appeared before me this day in person and acknowledged that he/she signed and delivered the said instrument as his/her own free
and voluntary act and as the free and voluntary act of said corporation, for the uses and purposes therein set forth.

 

GIVEN under my hand and notarial seal this _____
day of ________________, 20____.

 

	 	 
	 	Notary Public
	 	 
	 	My Commission Expires:
	 	 
	 	 

 

 

    	55

     

    

 

CONSENT AND AGREEMENT

 

The undersigned, referred to in the foregoing
securities purchase agreement as a guarantor, hereby consents and agrees to said securities purchase agreement and to the payment
of the amounts contemplated therein, documents contemplated thereby and to the provisions contained therein relating to conditions
to be fulfilled and obligations to be performed by it pursuant to or in connection with said securities purchase agreement to the
same extent as if the undersigned were a party to said securities purchase agreement.

 

GUARANTOR:

 

MEDICAL MIME, INC.

 

 

By:/s/ Seamus Lagan

Name: Seamus Lagan

Title:Secretary

 

	STATE OF ________________	)
	 	) SS.
	COUNTY OF ______________	)

 

 

The undersigned, a Notary
Public in and for the said County, in the State aforesaid, DO HEREBY CERTIFY that Seamus Lagan, the Secretary of Medical Mime,
Inc., a Florida corporation, who is personally known to me to be the same person whose name is subscribed to the foregoing instrument,
appeared before me this day in person and acknowledged that he/she signed and delivered the said instrument as his/her own free
and voluntary act and as the free and voluntary act of said corporation, for the uses and purposes therein set forth.

 

GIVEN under my hand and notarial seal this _____
day of ________________, 20____.

 

 

	 	 
	 	Notary Public
	 	 
	 	My Commission Expires:
	 	 
	 	 

 

    	56

     

    

 

CONSENT AND AGREEMENT

 

The undersigned, referred to in the foregoing
securities purchase agreement as a guarantor, hereby consents and agrees to said securities purchase agreement and to the payment
of the amounts contemplated therein, documents contemplated thereby and to the provisions contained therein relating to conditions
to be fulfilled and obligations to be performed by it pursuant to or in connection with said securities purchase agreement to the
same extent as if the undersigned were a party to said securities purchase agreement.

 

GUARANTOR:

 

EPINEX DIAGNOSTICS LABORATORIES, INC.

 

 

By:/s/ Norma Villar

Name: Norma Villar

Title:Chief Financial Officer

 

	STATE OF ________________	)
	 	) SS.
	COUNTY OF ______________	)

 

 

The undersigned, a Notary
Public in and for the said County, in the State aforesaid, DO HEREBY CERTIFY that Norma Villar, the Chief Financial Officer of
Epinex Diagnostics Laboratories, Inc., a California corporation, who is personally known to me to be the same person whose name
is subscribed to the foregoing instrument, appeared before me this day in person and acknowledged that he/she signed and delivered
the said instrument as his/her own free and voluntary act and as the free and voluntary act of said corporation, for the uses and
purposes therein set forth.

 

GIVEN under my hand and notarial seal this _____
day of ________________, 20____.

 

	 	 
	 	Notary Public
	 	 
	 	My Commission Expires:
	 	 
	 	 

 

    	57

     

    

 

CONSENT AND AGREEMENT

 

The undersigned, referred to in the foregoing
securities purchase agreement as a guarantor, hereby consents and agrees to said securities purchase agreement and to the payment
of the amounts contemplated therein, documents contemplated thereby and to the provisions contained therein relating to conditions
to be fulfilled and obligations to be performed by it pursuant to or in connection with said securities purchase agreement to the
same extent as if the undersigned were a party to said securities purchase agreement.

 

GUARANTOR:

 

EPINEX DIAGNOSTICS LABORATORIES, INC.

 

 

By:/s/ Norma Villar

Name: Norma Villar

Title:Chief Financial Officer

 

	STATE OF ________________	)
	 	) SS.
	COUNTY OF ______________	)

 

 

The undersigned, a Notary
Public in and for the said County, in the State aforesaid, DO HEREBY CERTIFY that Norma Villar, the Chief Financial Officer of
Epinex Diagnostics Laboratories, Inc., a Nevada corporation, who is personally known to me to be the same person whose name is
subscribed to the foregoing instrument, appeared before me this day in person and acknowledged that he/she signed and delivered
the said instrument as his/her own free and voluntary act and as the free and voluntary act of said corporation, for the uses and
purposes therein set forth.

 

GIVEN under my hand and notarial seal this _____
day of ________________, 20____.

 

 

	 	 
	 	Notary Public
	 	 
	 	My Commission Expires:
	 	 
	 	 

 

 

    	58

     

    

 

CONSENT AND AGREEMENT

 

The undersigned, referred to in the foregoing
securities purchase agreement as a guarantor, hereby consents and agrees to said securities purchase agreement and to the payment
of the amounts contemplated therein, documents contemplated thereby and to the provisions contained therein relating to conditions
to be fulfilled and obligations to be performed by it pursuant to or in connection with said securities purchase agreement to the
same extent as if the undersigned were a party to said securities purchase agreement.

 

GUARANTOR:

 

PLATINUM FINANCIAL SOLUTIONS, LLC

 

 

By:/s/ Pavlos Papageorgiou

Name: Pavlos Papageorgiou

Title:Manager

 

	STATE OF ________________	)
	 	) SS.
	COUNTY OF ______________	)

 

 

The undersigned, a Notary
Public in and for the said County, in the State aforesaid, DO HEREBY CERTIFY that Pavlos Papageorgiou, the Manager of Platinum
Financial Solutions, LLC., a Florida limited liability company, who is personally known to me to be the same person whose name
is subscribed to the foregoing instrument, appeared before me this day in person and acknowledged that he/she signed and delivered
the said instrument as his/her own free and voluntary act and as the free and voluntary act of said corporation, for the uses and
purposes therein set forth.

 

GIVEN under my hand and notarial seal this _____
day of ________________, 20____.

 

	 	 
	 	Notary Public
	 	 
	 	My Commission Expires:
	 	 
	 	 

 

 

    	59

     

    

 

 

PLATINUM FINANCIAL SOLUTIONS LTD.

 

 

By:_____________________________

Name:

Title:

 

	STATE OF ________________	)
	 	) SS.
	COUNTY OF ______________	)

 

 

The undersigned, a Notary
Public in and for the said County, in the State aforesaid, DO HEREBY CERTIFY that _______________________, the ______________________
of Platinum Financial Solutions Ltd., a Bahamian limited company, who is personally known to me to be the same person whose name
is subscribed to the foregoing instrument, appeared before me this day in person and acknowledged that he/she signed and delivered
the said instrument as his/her own free and voluntary act and as the free and voluntary act of said corporation, for the uses and
purposes therein set forth.

 

GIVEN under my hand and notarial seal this _____
day of ________________, 20____.

 

	 	 
	 	Notary Public
	 	 
	 	My Commission Expires:
	 	 
	 	 

 

 

    	60

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00249-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00249-of-00352.parquet"}]]